Publications and Reports
BioPlan Associates, Inc. delivers Biotech and Life Science Business Strategy Research and Analysis so our clients can make smarter, more effective business decisions. Our extensive market reports and publications cover biotechnology and biopharmaceutical manufacturing trends and insights, clinical trials, China CDMO and distributor growth, India biopharmaceutical market growth, and much more!
The following is our list of Publications and Reports.
Advances in Biopharmaceutical Technology in China, 2nd ed.
Advances in Biopharmaceutical Technology in India
Advances in Large Scale Biopharmaceutical Manufacturing
Biomanufacturing Manufacturing Capacity and Production, 2026
China Biomanufacturing Comparative Analysis
Quick Guide to Clinical Trials, 2nd ed.
Growth of Biopharmaceutical Contract Manufacturing Organizations in China
China Top Biopharmaceutical Manufacturing Directory, 2nd Ed.
Biopharmaceutical Expression Systems and Genetic Engineering Techniques
Quick Guide to Healthcare and Biotechnology in the Middle East
India Top 60 Biopharmaceutical Manufacturers
Top 60 Distributors of Bioprocessing Supplies in China
Webcasts
Drug Digest: Changes and Trends in the Outsourcing Landscape (2024)
In this episode of Drug Digest, Eric S. Langer, president and managing partner, BioPlan Associates discusses the current outsourcing landscape in the post-COVID world and the changes the pandemic has enforced in the demand for outsourced bioprocessing services.
Discovery Matters Podcast with CPhI (2021)
Dodi Axelson, Discovery Matters Podcast with CPhI talks with Eric Langer, Managing Partner of BioPlan Associates, about BioPlan’s Annual Report on Biopharmaceutical Manufacturing Capacity and Production.
China’s Emergence in Global Biopharma Manufacturing: Trends in the Chinese Biopharma Series (2018)
This four-part educational series, sponsored by BioProcess International and BioPlan Associates, Inc., highlights key trends emerging in China biopharmaceuticals, using select content from BioPlan Associates’ 2018 2nd edition report, Advances in Biopharmaceutical Technology in China, 2nd Ed., a unique, peer-reviewed study that incorporates the research and work from over 100 global industry expert authors, many based in China.
China Biopharma Opportunities – Watch Now
In Part 1, Michael Frizberg, President, CMAB – Switzerland and Hong Kong, highlights key drivers and areas of growth in China biopharma today, as well as cover areas of opportunities for expansion and revenue in today’s markets.
China Biopharma – A Hot Bed for Investments – Watch Now
In Part 2, Dr. Linda Pullan, Principal, Pullan Consulting, covers China investments, as well as advice for negotiating China deals.
China’s GMP Strategies: Dealing with Quality Management Issues – Watch Now
In Part 3, Fai Poon, President, QuaCell Biotech, Ltd., covers China regulatory issues, a review of current challenges in biopharma quality management in China, and opportunities for progress with growing CMO platforms and emerging CQO business.
Bioprocessing Challenges and CMO Opportunities – Watch Now
In Part 4, Dr. Scott Wheelwright, Co-Founder and Principal, Complya Asia, provides an overview of factors affecting manufacturing, manufacturing trends by market, biopharmaceutical manufacturing in China among CMOs and developing companies.
Continuous Processing: Technologies, Strategies, and Expertise for Process Intensification – BioProcess International, Renaud Jacquemart, March 2026
Media Optimization Strategies To Bring Down Costs: 36% of Facilities Want Better Supplements for Increased Titer in Bioprocessing – BioProcess International, Katrina Cordovado, May 2026
eBook: Biomanufacturing Capacity — Getting Creative in Complicated Global Markets – BioProcess International, Katrina Cordovado, Smita Khanna, Vicky Xia, June 2026
Single-Use Comes of Age—What’s Next? – Genetic Engineering News, Frances Lasowski and Renaud Jacquemart, August 2026
CDMO Capacity Crunch Persists – Contract Pharma, Katrina Cordovado, August 2026
Continuous Biomanufacturing and Perfusion Technologies Are Finally on the Cusp of Broad Adoption – BioProcess International, August 2026
Fill-Finish Contract Manufacturing for Biologics and Vaccines – Contract Pharma, Eric Langer, March 2025.
Outsourcing Hits Record Levels for All Bioprocess Platforms – Outsourced Pharma, Yasmin Timol, Ph.D., July 2025.
Biopharma Manufacturing Outsourcing Is Flexible, Not Fractured – Outsourced Pharma, Louis Garguilo, August 2025.
Report: Nearly 40% Of Biomanufacturers Eyeing Continuous Processing – BioProcess Online & Outsourced Pharma, Yasmin Timol, Ph.D., August 2025.
Single-Use Technologies: As Demand Rises, Tolerance for High Prices Falls – BioProcessing International, Yasmin Timol, Ph.D. August 2025.
eBook: Bioproduction Capacity — Continual Expansion To Meet Increasing Demands – BioProcessing International, Yasmin Timol, Ph.D., September 2025.
BioPharma By the Numbers: Rise of Bioprocessing Automation – BioPharm International, Eric Langer, September 2025.
BioPharma By the Numbers: Bioprocess Hiring Creating Capacity Constraints – BioPharm International, Eric Langer, October 2025.
Biomanufacturers Face Political and Staffing Headwinds – BioProcess International, Renaud Jacquemart, Ph.D., November 2025
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing – BioPharm International, Eric Langer, December 2025.
Survey: SUS Insufficient For 40% Of Biopharma – BioPharm International, Katrina Cordovado, December 2025.
21 New Downstream Technologies Being Considered To Fix Capacity Problems – BioProcess Online, BioPlan Staff, January 2024.
Continuous Manufacturing: Many Want It, But Here’s Why Few Have It – BioProcess Online, Ioanna Deni, February 2024.
Report: Single-use Bioreactor Uptake Plateaued, Other SUT On The Rise – BioProcess Online, Ioanna Deni, August 2024.
Wish SUS Cost Less? Survey Says Your Peers Do, Too – BioProcess Online, Ioanna Deni, September 2024.
Embracing single-use innovations in a post-COVID era – Pharma Manufacturing, Ioanna Deni, September 2024.
Post-COVID Trends in Biopharma Contract Manufacturing – Contract Pharma, Ioanna Deni, September 2024.
Top 50 Biopharma Products Drive Growth in Contract Manufacturing – Contract Pharma, Dr. Smita Khanna, October 2024.
Survey Says Downstream Biomanufacturing Bottleneck Is Over – BioProcess Online, Ioanna Deni, October 2024.
The Waiting Game: A Bottom Is Imminent For Bioprocessing In China With A Return To Growth Two Years Away – CPhI Online Trends, Vicky Q. Xia, October 2024.
Great Majority of Biomanufacturers to Outsource More Production Over the Next Five Years – CPhI Online Trends, Ioanna Deni, October 2024.
Biopharmaceutical Manufacturing Growth – Pharmaceutical Technology, Shriya Bhatkhande, February 2023.
Single-Use Bioprocessing Technologies Enabling More Rapid Vaccines Production – American Pharmaceutical Review, Shriya Bhatkhande, April 2023.
Demand Surges for Cell and Gene Therapy Contract Manufacturing – Contract Pharma, Arvind S. Deol and Eric S. Langer, May 2023.
Post-COVID Supply-Chain Challenges Are Easing, Part 1: New Competition Is Changing Industry’s Buying Behavior – BioProcess International, Eric Langer and Bob Brooks, BioPhorum, June 2023.
Post-COVID Supply-Chain Challenges Are Easing, Part 2: Impact of Increased Vendor Competition on Pricing – BioProcess International, Eric Langer and Bob Brooks, BioPhorum, August 2023.
Staffing Shortages: Major Hurdle for Bioprocess Contract Manufacturing Services in 2023 – BioPharm International, Shriya Bhatkhande, August 2023.
Survey Results Show What Could Finally Make Sustainability Stick – BioProcess Online, Doug Nissinoff, September 2023.
CPHI report: China develops own biologics niche; no longer low-cost manufacturer – Bioprocess International, Vicky Xia, September 2023.
Symbiotic Success: How CDMOs Shaped a Decade of Biomanufacturing – Contract Pharma, Doug Nissinoff, October 2023.
Here’s Why Outsourcing To CDMOs Doubled In 13 Years – BioProcess Online, Erica Friedman, October 2023.
Modular And Single-use Tech Driving The Future Of Biomanufacturing – BioProcess Online, Erica Friedman, November 2023.
Top 50 Biopharma Products Drive Growth in Contract Manufacturing – Contract Pharma, Arvind S. Deol and Dr. Smita Khanna, November 2023.
Top Biomanufacturing Trends for 2022 – DCAT, Joel Ranck, January 2022
2021’s Bioprocessing Year In Review & 7 Key Takeaways – DCAT, Dr. Smita Khanna, January 2022
The Single-use Bioprocessing Bottleneck & Looking Ahead – BioProcess Online, Dr. Paul Spencer, April 2022
Biopharma In China: The Emerging Global Force Of Domestic Suppliers – BioProcess Online, Vicky Xia and Leo Yang, May 2022
Contract Manufacturing During COVID: Biologics revenue increases 29%, but will this growth be sustainable? – Contract Pharma, Eric Langer, May 2022
2022 Outsourcing Trends In Biopharmaceutical Manufacturing – BioProcess Online, Dr. Smita Khanna, June 2022
Bioprocessing Sees Continued Improvements In Batch Failure Reductions In 2022 – BioProcess Online, Joel Ranck, July 2022
BioPlan report: Buoyant bioprocess space will continue to shine post-COVID – BioProcess International, Dan Stanton, October 2022
Cell and Gene Therapy Contract Manufacturers Are Critical to Industry Success – Contract Pharma, Joel Ranck, September 2022
Will China become an innovation hub? CPHI Annual Report 2022 highlights four key trends in China’s emerging innovative biopharma industry – Pharmaceutical Manufacturing, Vicky Xia, October 2022
The Biopharmaceutical Industry and Bioprocessing: What to Expect in 2021 – DCAT, Ronald A. Rader and Eric S. Langer, January 2021
Top Trends in Biomanufacturing 2020 – BioProcess International, Ronald Rader, February 2021
Economics of Perfusion Culture Media and Upstream Processing – American Pharmaceutical Review, Ronald Rader, Eric Langer, February, 2021
Worldwide Biopharmaceutical CMO Capacity Analysis – BioProcess International, Ronald Rader and Eric Langer, February 2021
The “New Normal”: Changing Perceptions on Bioprocess Intensification and Continuous Bioprocessing – BioProcess Online, Ronald A. Rader, March 2021.
Supply Chain Challenges Creating Hurdles to COVID-19 Vaccine Production [PDF] – BioPharm International, Jonathan S. Dakin, April 2021
Cell & Gene Therapy Bioprocessing: Demand For Better Process Control, Expertise & CMOs – BioProcess Online, Ronald Rader and Eric Langer, May 2021
Trends Affecting Biopharmaceutical Manufacturing – BioPharm International, David Lin, September 2021
Biopharma outsourcing goes international – Pharma Manufacturing, David Lin, October 2021
COVID-19 Spurs Growth Of China’s Domestic Bioprocessing Suppliers – BioProcess Online, Vicky Xia and Leo Yang, October 2021
2019 FDA Biopharmaceutical Approvals WP (published Jan 2020), Ronald Rader
Biosimilar Pipeline Experiencing 12% Annual Growth: A Progress Update – BioProcess Online, Ronald Rader, March 2020
Covid 19: Impact on Bioprocessing and Outsourcing – Contract Pharma, Ronald Rader and Eric Langer, May 2020
Biomanufacturing: Demand for Continuous Bioprocessing Increasing – Pharmaceutical Technology/BioPharm International, Eric Langer, June 2020
Cell And Gene Therapy Bioprocessing: Hiring And Capacity Crunch On The Horizon – BioProcess Online, Eric Langer June 2020
Culture Media Market Growth Drives Demand For New & Better Technologies – BioProcess Online, Kamna Jhamb, Ph.D., July 2020
COVID-19’s Impact On Bioprocessing: Insights From Industry Leaders – BioProcess Online, Ronald A. Rader, Eric S. Langer, and Kamna Jhamb, Ph.D, August 2020
Finding a Committed Bioprocess Supply Distributor in China: Managing Distributors in a Rapidly Growing Market – Genetic Engineering News, Vicky Xia and Leo Yang, September 2020
Samsung’s Drugmaking Future Includes a $2 Billion ‘Super Plant’ Bigger Than the Louvre – Wall Street Journal, Featuring quote from Eric S. Langer, Sept 2020
Cellular and Gene Therapies Face a Manufacturing Capacity Crunch – Pharmaceutical Technology/BioPharm International, Ronald Rader, September 2020
CONTINUOUS BIOPROCESSING: WHEN WILL WE SEE COMMERCIAL SCALE OPERATIONS? – Teknoscienze and ChemOutsourcing, Ronald Rader, October 2020
Biopharma trends accelerate: The pandemic has amplified the industry’s hiring problems and growth – Pharmaceutical Manfacturing, Ronald Rader, October 2020
Accelerating Trends in Bioprocessing COVID-19 Crisis Intensifies Need for Collaborative Solutions – American Pharmaceutical Review, Ronald A. Rader, Eric S. Langer, and Kamna Jhamb, Ph.D, October 2020
Biologics Manufacturing In China: Competition Heats Up Among CMOs & Their Clients – BioProcess Online, Vicky Xia and Leo Yang, October 2020
Global trends and growth opportunities in the biopharmaceutical product development and manufacturing – CPhI, Eric Langer, October 2020
Growth of Domestic Mab Pipeline, Regulatory Reform and New Investment is changing the landscape of Biologics CDMOs in China – CPhI, Vicky Xia and Leo Yang, October 2020
Cell and Gene Therapies: Challenges in Scale-up to Commercial Manufacturing – Results Healthcare, Ronald Rader, December 2020
Bioprocessing Year In Review: 11 Key Trends Accelerated By COVID-19 – BioProcess Online, Ronald Rader and Eric Langer, December 2020
Biomanufacturing Capacity and Supplies: COVID’s Impact – DCAT, Ronald Rader and Eric Langer, December 2020
The Outlook for CMO Outsourcing in 2019 – BioPharm International, Jan 2019, Ronald Rader and E. Langer
Worldwide Biopharmaceutical CMO Capacity Analysis – Feb 2019, BioProcess International, Ronald Rader and E. Langer
Part 2 – Can China Become a Top Destination for Biologics Manufacturing? – Market Research Blog, Feb 18, 2019, Eric Langer
China Can Be Ignored No Longer: Long-Term Biopharmaceutical Opportunities Based on Near-Term Demonstrated Growth – BioProcess International, March 2019, Vicky (Qing) Xia and E. Langer
Biosimilars Set to Further Expand the Biopharmaceutical Market – American Pharmaceutical Review, March 2019, Ronald Rader and E. Langer
CMOs Leading the Way on Single-Use Systems Adoption – Pharmaceutical Technology, March 2019, Ilene Roizman and E. Langer
Biosimilars Pipeline Shows Remarkable, Sustained Growth – BioProcess Online, March 2019, Ronald Rader
Disposables/Single-Use Roundtable – American Pharmaceutical Review, March 2019, Eric Langer
Bioprocessing Facilities and FDA Inspection Problems – BioPharm International/Pharmaceutical Technology, May 2019, Ronald A. Rader
China Looks Inward and Outward: Investments in US and EU Biopharmaceutical Companies Are on the Rise – BioProcess International, May 2019, Vicky Xia and Eric S. Langer
Trends In Single-Use System Adoption In The Biopharma Industry – BioProcess Online, June 2019, Ilene Roizman
Good Manufacturing Practice in China: Equipment Strategy and Quality Management to Compete with the West – BioProcess International, June 2019, Vicky Xia
Outsourcing in China: How far can it go? – Contract Pharma, July 2019, Vicky Xia
Asia Bioprocessing Capacity Trends: Overall Growth, But Cell Therapy Shortages Loom – BioProcess Online, August 2019, Vicky Xia
Trends To Watch In China’s Biopharma Industry – BioProcess Online, October 2019, Vicky Xia
China’s single-use craze – Pharma Manufacturing, October 2019, Vicky Xia
Trends in Biopharma Contract Manufacturing in China and India – CPhI, November 2019, Vicky Qing Xia & Ronald A. Rader
Biopharma Over 20 Years – Contract Pharma, K. John Morrow, Jr. and E. Langer, November 2019
The next decade of cleanrooms – Pharmaceutical Manufacturing, Ronald A. Rader, December 2019
Biopharma Year in Review – Looking Ahead to 2020 – Pharmaceutical Online/BioProcess Online, December 2019, K. John Morrow Jr. and E. Langer
Biosimilars on Cusp of Far-Reaching Impact; BioCompare; January 2018, Ronald A. Rader
Current Challenges in Bioprocesses Development; Pharmaceutical Technology; March 2018, Ronald A. Rader
CMOs & Biosimilars Mfg. in the U.S.; Contract Pharma; April 2018, Eric S. Langer and Ronald A. Rader
Contract Biomanufacturing in China: Creating a New Segment; Contract Pharma; April 2018, Vicky Xia and Leo Yang.
eBook: The Commercial Expression Systems Market — What Has Changed in the Past Decade; BioProcess International; May 2018, R. Rader
Demand for Capacity Drives China’s Biomanufacturing Expansion; BioProcess International; June 2018, Vicky Qing Xia and Leo Cai Yang
Fifteen Years of Progress: Biopharmaceutical Industry Survey Results; BioPharm International; July 2018, R. Rader
Biopharmaceutical Manufacturing is Shifting to Single-Use Systems. Are the Dinosaurs, the Large Stainless Steel Facilities, Becoming Extinct?;American Pharmaceutical Review; October 2018, E. Langer.
Top 12 Biopharma Manufacturing Trends; Genetic Engineering News; October 2018, E. Langer.
Improving Training in Biopharmaceutical Manufacturing; BioProcess Online; October 2018, I. Roizman and E. Langer.
7 Reasons There Was Never Going To Be A Bioprocessing Capacity Crunch; Outsourced Pharma; October 2018, Louis Garguilo (interview with R. Rader and E. Langer).
eBook: Biopharma Manufacturing Markets: Biomanufacturing contract services and supplies markets continues to expand; Contract Pharma; November 2018, R. Rader and E. Langer.
Staffing shortage leaving blockbuster biologics undeveloped, says expert; BioProcess International; November 2018, Dan Stanton (interview with E. Langer).
eBook: Single-Use Bioprocessing Equipment Trends and Adoption by CMOs; Pharmaceutical Technology; November 2018, R. Rader and E. Langer.
Part 1 – China Biopharmaceutical Growth Exceeding Western Projections – Market Research Blog, Nov 28, 2018, Eric Langer
Top Trends In The Biopharmaceutical Industry And Bioprocessing For 2019; BioProcess Online; December 2018, R. Rader and E. Langer.
Overcoming The Manufacturing Hurdles Of Cell & Gene Therapy; BioProcess Online; February 2017, R. Rader
Modular Bioprocess Facilities Expanding Capacity in China; Genetic Engineering News; March 2017, V. Xia
CMOs Hiring Constraints: Cell Therapy Manufacturing Expecting Future Challenges; Contract Pharma; March 2017, E. Langer
Biosimilar Markets and Regulation: Which Countries Are Going All In?; BioProcess International; April 2017; R Rader
Staffing for China’s Rapidly Growing Biomanufacturing Industry; Pharmaceutical Technology; April 2017, V. Xia
CMOs & Biosimilars Mfg. in the U.S.; Contract Pharma; April 2017, E. Langer and R. Rader
Trends in Bioprocess Automation: Quality Control and Process Analytical Technology in High Demand; BioProcessing Journal; Spring 2017, K. Estes and E. Langer
Driving Bioprocessing Efficiency; Pharmaceutical Manufacturing; May 2017, K. Estes and E. Langer
China Biopharma: Is a Wave of GMP Exports in Our Future?; PharmaFocus Asia; May 2017, V. Xia, L. Yang, E. Langer
Update on Continuous Bioprocessing: From the Industry’s Perception to Reality; Pharmaceutical Technology; June 2017, K. Estes and E. Langer
Chinese And Indian GMP Biologics Exports: Surveying The Current Landscape; BioProcess Online; June 2017, V. Xia, L. Yang, E. Langer
Trends in New Technologies & Budgets; Contract Pharma; June 2017, E. Langer
Trends in Biopharma Contract Manufacturing in China and India; Pharmaceutical Outsourcing; June 2017, V. Xia and R. Rader
2 part series – Chinese & Indian Expectations For GMP Biologics Exports — A Comparative Assessment; BioProcess Online; July 2017, V. Xia, L. Yang, E. Langer
Current Trends in Analytical Testing; Contract Pharma; May 2017, E. Langer
Biosimilars Paving The Way For Cost-Effective Bioprocessing; BioProcess Online; August 2017, R. Rader and E. Langer
Outsourcing Trends in Biopharmaceutical Manufacturing; Pharmaceutical Outsourcing; September 2017, E. Langer
Trends and Growth in Single-Use System (SUS) Adoption; American Pharmaceutical Review; October 2017, E. Langer
Downstream Gears Up; Pharmaceutical Manufacturing; November 2017, E. Langer
Cell and Gene Therapies: Industry Faces Potential Capacity Shortages; Genetic Engineering News; November 2017, Ronald Rader
Hiring and Staffing in Biopharmaceutical Manufacturing: Five-Year Trends Indicate Difficulty in Filling Positions; Bioprocess International; January 2016; E. Langer
Alternatives to Protein A: Who’s Investigating?; Genetic Engineering News; February 2016, E. Langer
New Technologies for Fill-Finish; CMOs Are Well Positioned as Early Adopters; Genetic Engineering News; February 2016, E. Langer
Taking Stock of Biopharma’s Outsourcing Markets; Contract Pharma; February 2016, E. Langer
CMOs Step Up in Areas Where BioPharma is Short-Staffed; Pharmaceutical Outsourcing; March 2016, E. Langer
What’s Holding Back Single-Use Adoption?; Pharmaceutical Processing; March 2016, E. Langer
4 Key Trends In Biopharmaceutical Manufacturing In 2016; BioProcess Online; April 2016, E. Langer
Future Manufacturing Strategies for Biosimilars; BioProcess International; May 2016, R. Rader and E. Langer
Outsourcing of Biomanufacturing in 2016; Pharmaceutical Technology; May 2016, E. Langer
Biosimilars Segment—A Fast-Moving Blur; Genetic Engineering News; June 2016, E. Langer
Biomanufacturing Outsourcing Budgets Grow, Slowly; Pharmaceutical Technology; June 2016, E. Langer
Microbial Platforms Set for Rapid Growth; Genetic Engineering News; July 2016, E. Langer
Contract Manufacturing Budget Trends: Study shows where the money is, and isn’t, flowing; Contract Pharma; July 2016, E. Langer
Biosimilars Pipeline Analysis: Many Products, More Competition Coming; BioProcess Online; July 2016, R. Rader
CMOs and Innovation; Pharmaceutical Outsourcing; August 2016, E. Langer
Hiring Difficulties Compound Downstream Processing Woes; Genetic Engineering News; September 2016, E. Langer
Economics of In-House Buffer Preparation: Evaluating the cost effectiveness of keeping basic ops in-house; Contract Pharma; September 2016, E. Langer
Biopharmaceutical Manufacturing Globalization Continues; Pharmaceutical Outsourcing; September 2016, E. Langer
Average Batch Failure Rate Worsens; Genetic Engineering News; October 2016, E. Langer
Fill/Finish Outsourcing: This key bioprocessing segment is expecting continued growth; Pharmaceutical Technology; October 2016, E. Langer
Continuous Bioprocessing Overtakes Single-Use On List Of Top Technology Trends; BioProcess Online; October 2016, E. Langer
Year-End Trends in Biopharma Contract Manufacturing; Contract Pharma; November 2016, E. Langer
Manufacturing Costs Will Be Critical to Biosimilars’ Success; Pharmaceutical Manufacturing; November 2016, R. Rader
Biopharmaceutical Manufacturing Growing Rapidly in China; Genetic Engineering News; December 2016, E. Langer
Biosimilars Supporting Contract Manufacturers’ Growth: Biosimilars may be the key to CMO growth; Pharmaceutical Technology; December 2016, E. Langer
2017 Biopharmaceutical Trends — Opportunities For The New Year; BioProcess Online; December 2016, E. Langer
Fill/Finish Capacity Use for Biologics; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; January 2015, E. Langer
Biosimilars Impacting CMO Capacity; Pharmaceutical Outsourcing; February 2015; E. Langer
7 Top Trends in Biomanufacturing Outsourcing; Contract Pharma; January 2015; E. Langer and J.C. Lupis
CMO’s Plan for Capacity Expansions; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; March 2015, E. Langer
30 Years of Upstream Productivity Improvements; BioProcess International; February 2015; R. Rader and E. Langer
A Fully Disposable Bioprocessing Facility: Is it on the horizon?; Pharma IQ; February 2015; E. Langer
Outsourcing Budgets Continue to Shine: Preliminary study data indicates continued spending on outsourcing; Contract Pharma; April 2015, E. Langer
Biomanufacturing Outsourcing Globalization Continues; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; May 2015; E. Langer
Leachables And Extractables In Single-Use: Trends and Expectations Over Plastics Innovation; BioProcess Online, LSL; March 2015; E. Langer
Biosimilars Improving Efficiency, Cost for All Biologics; Contract Pharma; April 2015, E. Langer
BioPharma Industry Seeks Downstream Processing Advances; Pharmaceutical Processing; June 2015; E. Langer
Another In-House Operation Gets Outsourced; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; June 2015; E. Langer
Key Trends Shaping Fill/Finish Operations From Single-Use Adoption to CMO Acquisitions— Trends to Watch for This Year; American Pharmaceutical Review/Pharmaceutical Outsourcing; May 2015; E. Langer
Critical Trends Driving BioManufacturing Production Strategies; Pharmaceutical Manufacturing; June 2015; E. Langer
CMOs Demanding Easier-to-Integrate Single-use Devices; Contract Pharma; May 2015; E. Langer and J.C. Lupis
Single-Use Standardization: Is It Holding Back The Biopharma Industry?; BioProcess Online, LSL; June 2015; E. Langer
Hiring in Biopharma: Rapid Industry Growth is Creating Bottlenecks; Pharmaceutical Processing; July 2015; E. Langer
Getting to Yes; Contract Pharma; July 2015; E. Langer
New Technologies for Downstream Efficiencies; Pharmaceutical Manufacturing; June 2015; E. Langer
Outsourcing Becoming More Cost Competitive; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; August 2015; E. Langer
Is Biopharma Ready to Say Goodbye to Batches?; Medicine Maker; August 2015; E. Langer
CMOs Concerned With Cost of Single-Use Equipment; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; September 2015; E. Langer
CMOs Are Willing to Pay for More Innovation; Contract Pharma; September 2015; E. Langer
Bio Pharma Manufacturing’s Top 15 Trends for 2015; Pharmaceutical Manufacturing; August 2015; E. Langer and J.C. Lupis
Globalization Hits Biopharma Contract Manufacturing; Contract Pharma; October 2015; E. Langer
Advances in Bioprocessing: Single-Use and Stainless Steel Technologies; BioProcessing International; December 2015; E. Langer
Biopharmaceutical Manufacturing: Historical and Future Trends in Titers, Yields, and Efficiency in Commercial-Scale Bioprocessing; BioProcessing Journal; Winter 2015; R. Rader and E. Langer
Are CMOs Really Going to See a Capacity Pinch?; Genetic Engineering News; November 2015; E. Langer
2015 in Review: 6 Key Trends Affecting CMOs; Contract Pharma; November 2015; E. Langer
Continuous Bioprocessing in Operation; Genetic Engineering News; December 2015; E. Langer
Cell Culture Media Process Optimization; Genetic Engineering News; December 2015, E. Langer
Regulatory Concerns For Facilities Of The Future: Does Flexibility Come With A Cost?; BioProcess Online, LSL; December 2015; E. Langer
Year in Review: Key Outsourcing Trends to Watch This Year; Pharmaceutical Outsourcing, January 2014; E. Langer
Novel Expression Systems Opening CMO Opportunities; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, January 2014; E. Langer
Who’s Improving Bioprocessing In 2014; Life Science Leader, January 2014; E. Langer
Continuous Bioprocessing and Perfusion: Wider Adoption Coming as Bioprocessing Matures; BioProcessing Journal, Spring 2014; E. Langer
Outsourcing trends in Biopharmaceutical Manufacturing; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, February 2014; E. Langer
Single Use Technologies in Biopharmaceutical Manufacturing: A 10-year Review of Trends and the Future; Engineering in Life Sciences, May 2014; E. Langer
Too Much CMO Capacity? Biomanufacturers plan their 2018 capacity expansions; Contract Pharma, March 2014; E. Langer
Best Practices in Biomanufacturing Supplier Relations: Reducing Raw Materials Risks; Life Science Leader; February 2014; E. Langer
Bioprocess Advances Drive Vaccine Manufacturing in Developing Countries; BioProcess International, February 2014; E. Langer and R. Rader
Innovation Is This Year’s Magic Wand; Genetic Engineering News, March 2014; E. Langer
Powders and Bulk Liquids; Bioprocess International, March 2014; E. Langer and R. Rader
Innovation in Pre-packed Disposable Chromatography Columns; BioPharm International Supplement, March 2014; E. Langer
Manufacturers Open Their Wallets for Outsourcing: Accessing Technical Expertise and Cutting Costs; BioProcess International, April 2014; E. Langer
Biopharma Quality Management Best Practices: An Approach to Quality Initiatives; Life Science Leader, April 2014; E. Langer
Outsourcing No Longer Just for Cost-Cutting; Pharmaceutical Technology, May 2014; E. Langer
CMOs Most Critical to Success Factors; Pharmaceutical Processing, April 2014; E. Langer
Bioprocessors Demanding Single-Use Sensors Best Practices; Life Science Leader, May 2014; E. Langer
Bioprocessing Trends to Expect in 2014; Genetic Engineering News, June 2014; E. Langer
Bio/Pharma Industry Improves Downstream Operations Best Practices: Membrane Technology Options; Life Science Leader, July 2014; E. Langer
BioPharma Unhappy With Suppliers’ Progress on Single-Use Hookups; BioProcess International, September 2014; E. Langer
Biopharm Executives Point to Better CMO Performance; Contract Pharma, October 2014; E. Langer
Outsourcing Grows in Europe; Pharmaceutical Technology Europe, August 2014; E. Langer
Outsourcing Media and Buffer Prep; Contract Pharma, September 2014; E. Langer
Targeting Different Offshore Destinations; Pharmaceutical Technology, September 2014; E. Langer
Outsourcing Economic Models Are Changing; Life Science Leader, September 2014; E. Langer
Moving Beyond the Batch: Best Practices, Opportunities and Challenges in Continuous Bioprocessing; Life Science Leader, October 2014; E. Langer
Bioprocessing Challenges of Antibody-Drug Conjugates; BioProcess International, October 2014; R. Rader
Budgets Increase to Support Single-Use Bioprocessing; BioPharm International, November 2014; E. Langer
Single-use Disposables are Future Proofing Biopharmaceutical Manufacturing; PharmaIQ, October 2014; E. Langer
The Biosimilars Opportunity: 4-years of Waiting; Life Science Leader, October 2014; E. Langer
Risks and Rewards in the U.S. BioSimilars Pipeline; Pharmaceutical Manufacturing, October 2014; E. Langer
The US Biosimilars Future Is Hard to Predict: Global Health Policy, Innovation, Prices, and Profits Are All at Stake; BioProcess International, December 2014
Biomanufacturing Industry Not Providing Employees the Tools to Succeed; Life Science Leader, November 2014; E. Langer
Year in Review: Trends in Biopharma Manufacturing Outsourcing; Pharmaceutical Technology, December 2014; E. Langer
Critical Innovation BioProcessing Trends For 2014; Life Science Leader, December 2013; E. Langer
Disposable Chromatography: Options Are Increasing Requirements for greater productivity and efficiency are moving interest toward disposable options; Genetic Engineering News, December 2013; E. Langer
Biopharmas Increasingly Satisfied With Vendors Of Single-Use Products; Life Science Leader, December 2013; E. Langer
Future proofing biopharmaceutical manufacturing: the industry seeks a leaner version of itself; Future Science, December 2013; E. Langer and R. Rader
CMOs Demanding More Innovations; Contract Pharma, November 2013
Innovation In Stainless-Steel Bioprocessing; Life Science Leader, October 2013; E. Langer and R. Rader
Seeking Innovation to Solve Persistent Problems; Pharmaceutical Manufacturing, November 2013; E. Langer
Bio-CMO Capacity Constraints; Contract Pharma, September 2013; E. Langer
Industry Adoption of Membrane Adsorbers; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, October 2013; E. Langer
Client Relationships: How CMOs Can Avoid The Pitfalls; Life Science Leader, October 2013; E. Langer
Innovation In Alternative Chromatography; Life Science Leader, October 2013; E. Langer
PAT Adoption Hurdles Remain; Pharmaceutical Manufacturing, October 2013; E. Langer
Making the Best of a Bad CMO-Client Relationship; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, September 2013; E. Langer
Innovation In Expression Systems Yields Increase Productivity; BioProcess Online, August 2013; E. Langer
Bioprocessing Advances in Vaccine Manufacture; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, September 2013; E. Langer and R. Rader
What Happened to Outsourcing in Asia?; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, August 2013; E. Langer
Innovation In Disposable Connectors; Life Science Leader, July 2013; E. Langer
Demand For Innovation In High-Value Bioprocessing; Life Science Leader, June 2013; E. Langer
Disposable Applications Penetrate Biomanufacturing Market; Pharmaceutical Manufacturing, June 2013; E. Langer
Keeping New Technologies Coming; BioProcess International, June 2013; E. Langer
Outsourcing’s Modest Role as a Cost-Containment Strategy; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, May 2013; E. Langer
CMOs Leading The Way In Biopharma Innovation – No Herd Mentality; Life Science Leader, May 2013; E. Langer
Outsourcing of Fill-Finish Operations Continues; Pharmaceutical Processing, April 2013; E. Langer
Global Changes in Biomanufacturing; A retrospective analysis of CMO Trends; Contract Pharma, April 2013, E. Langer
Single-use Bioprocessing Sensor Innovation Is In Need; Life Science Leader, April 2013; E. Langer
Vendors Ignore Calls For Innovation In Assays; Life Science Leader, April 2013; E. Langer
Biopharma Continues Globalization Efforts; Global Corporate Xpansion, April 2013; E. Langer
Focus on Efficiency: Single-use, analytical methods and downstream processing at the forefront.; Pharmaceutical Manufacturing, March 2013; E. Langer
Outsourcing of Non-traditional Protein Expression Systems Increases; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, April 2013; E. Langer
The Big Squeeze; European Biopharmaceutical Review, Spring 2013; E. Langer
Fill-Finish Innovation: Showing Sparks of Life; Contract Pharma, March 2013; E. Langer and R. Rader
Innovation In Assays And Analytical Methods Urgently Needed; Life Science Leader, February 2013; E. Langer
Biopharmas Increasingly Satisfied With Vendors Of Single-Use Products; Pharmaceutical Online, February 2013; E. Langer
The Future of BioPharma; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, February 2013; E. Langer
Offshoring Biomanufacturing; Pharmaceutical Technology, February 2013; E. Langer
Breaking the Biotech Bottleneck: Downstream capacity still lags behind upstream, but shortages are now “acute” rather than “chronic; Pharmaceutical Manufacturing, January 2013; E. Langer
Sponsors Look to Asia for Potential Contract Partners; BioProcessing International, January 2013; E. Langer
Biopharma Outsourcing Leveling Out; Pharmaceutical Online, August 2012, Eric Langer
Gauging Biopharm Outsourcing; Pharmaceutical Technology August 2012, Eric Langer
CMOs and Biodevelopers Taking Different Approaches to DSP Problems: CMOs Get Serious About New Technologies; E. Langer, Pharmaceutical Outsourcing, July 2012
Top 50 (or so) Biopharma Products: Ranking the top 57 biopharma products by 2011 revenues – Contract Pharma, Ronald Rader, July 2012
BioPharma Industry Gives the Nod to Single-Use Bioreactors; E. Langer, Genetic Engineering News, July 2012
Biomanufacturing Innovation; E. Langer, BioPharm International, July 2012
Biopharmas Increasingly Satisfied with Vendors of Single-Use Products; E. Langer, Life Science Leader, July 2012
Biomanufacturers Looking for Single-Use Innovations; E. Langer, Pharmaceutical Online, June 2012
Biomanufacturing Shows Signs of Maturity, PAT Adoption; E. Langer, June 2012
Biomanufacturing Innovation; E. Langer, Pharmaceutical Technology, June 2012
25 Years of Biopharma Industry Growth; E. Langer, BioPharm International, June 2012 Special Issue
Hiring In Biopharma — Where Are The Jobs Going Next?; E. Langer, Life Science Leader, May 2012
10 years of biomanufacturing: Industry maturity shown in the shifts toward process improvement; E. Langer, BioProcess International, May 2012
Single-Use Technologies Used Less for Downstream Purification Issues; E. Langer, Pharmaceutical Online, May 2012
Bio-Growth Slowing?; E. Langer, Contract Pharma, May 2012
Productivity Focus: CMOs Look to Get More From Their Employees; E. Langer, Genetic Engineering News, May 2012
BioManufacturers Increasing Budgets for New Technologies; Eric Langer, BIO, May 3, 2012
CMOs on the Hunt for Disposable Solutions; E. Langer, Pharmaceutical Processing, April 2012
BioPharma Industry Getting Comfortable with Complex Single Use Devices; E. Langer, Pharmaceutical Online, March 2012
Biopharma Vendor Satisfaction: Are Suppliers Doing What’s Best For The Industry?; E. Langer, Life Science Leader, March 2012
Industry Adopting More Complex Devices; E. Langer, Contract Pharma, March 2012
Pharmaceutical Outsourcing Trends: The Next Decade; E. Langer, BioPharm International, March 2012 Special Issue
Are Downstream Problems Finally Being Resolved?; E. Langer, BioProcess International, March 2012
Biosimilars and Biobetters; Eric Lanager, Pharmaceutical Processing, Feb 2012
Biomanufacturing Outlook; Eric Langer, Pharmaceutical Technology, Feb 2012
Biopharma Manufacturers Looking for Product Innovation; E. Langer, Life Science Leader, February 2012
Single Use Biomanufacturing Devices in High Demand; E. Langer, Pharmaceutical Online, February 2012
Upstream Single-Use Bioprocessing Systems; Ron Rader and Eric Langer, BioProcess International, February 2012
Biopharmaceutical Industry in 2012: Optimism on the Rise; E. Langer, Pharmaceutical Technology, February 2012
Biopharma Industry Enthusiastic About 2012; Eric Langer, BIO, January 12, 2012
Limited Analytical Technologies Are Inhibiting Industry Growth; E. Langer, October 2011
Top 1000 Global Biomanufacturing Facilities- Insights from real-time ranking of global biomanufacturing capabilities.; E. Langer, BioPharm International, August 2011
Can Outsourcing GMP Operations to China Really Work?; E. Langer, Life Science Leader, August 2011
Single Use Bioreactors Lead in New Use and Market Penetration; E. Langer, Pharma IQ, August 2011
Single Use Devices-Whats REALLY Holding Up Adoption?; E. Langer, Life Science Leader, July 2011
Positive Trends in Biomanufacturing Budgets: Biopharma and Vendor Budgets Are Up For the First Time in Three Years; E. Langer, BioProcessing Journal, July 2011
Hiring In Biopharma — Where Are The Jobs Going Next?; E. Langer, Life Science Leader, July 2011
Bio-Outsourcing On the Rise: Fewer companies go 100% in-house; E. Langer, Contract Pharma, June 2011
Will Perfusion Be the Next Revolution in Bioprocessing?; E. Langer, BioProcess International, June 2011
Offshoring Biomanufacturing: China rises to the top as a destination for international sourcing; E. Langer, BioProcess International, June 2011
Biomanufacturing Budget Bump-2011’s Spending Upswing; E. Langer, PharmaIQ, June 2011
Top 1000 Biomanufacturing Facilities: Knowing where key biomanufacturing facilities are located around the world is essential for decision-making.; E. Langer, BioPharm International, June 2011
Trends in Biopharmaceutical Industry: Budgets Returning…Investing In Innovation…Productivity & Cost Control; E. Langer, Pharmaceutical Manufacturing, June 2011
Biotech Budgets: Whose Departments Are Winning?; E. Langer, Life Science Leader, June 2011
Biopharma Wants Better Upstream Bioprocessing Technologies; E. Langer, Pharmaceutical Technology, May 2011
Downstream Process Bottlenecks: Industry Demanding Better Technologies; E. Langer, Genetic Engineering News, May 2011
Hiring Trends in Biopharma; E. Langer, Ashton Tweed, May 2011
Time to Build ‘Relationship’ into the Outsourcing Process; E. Langer (BioData Points), Life Science Leader, May 2011
Single Use Technologies Changing the Biomanufacturing Landscape; E. Langer, Life Science Leader, May 2011
Single Use Trends Boosting Adoption or Vendor Satisfaction; E. Langer, Pharmaceutical Manufacturing, May 2011
New Plant Expression Systems Drive Vaccine Innovation and Opportunity; E. Langer, BioProcess International, April 2011
Productivity Bottlenecks Drive the Demand for Innovation; E. Langer, BioProcess International, March 2011
Improved Downstream Technologies Are Needed to Boost Single-Use Adoption; E. Langer, BioProcess International, March 2011
Single-Use Products in BioManufacturing: Innovations Driving the Industry; E. Langer, BioProcess International, March 2011
Changes Underway for Biopharmaceutical Outsourcing More crucial biomanufacturing operations are expected to be outsourced
E Langer Presents 2011 Trends for Life Science Leader Journal; E. Langer, Life Science Leader Journal, January 2011
European Biomanufacturing Efficiency Outstripping US: Outlook for Capacity Utilisation Through 2015; E. Langer, European Biopharmaceutical Review, January 2011
Biofuels: Road to Recovery; D. Mousdale, BioFuels International, December 2010
Outsourcing Winners in 2014: Post recession and beyond; E. Langer, Pharmaceutical Technology, Nov 2, 2010
Trends to Watch in the Biopharmaceutical Industry; E. Langer, Pharmaceutical Executive, Supplement for Nov. 2010
Regulatory Challenges Impede Adoption of new Downstream Technologies; E. Langer, BioPharm International, October 2010
Plant Expression Systems Growing Rapidly, Vaccines Manufacturers Leading the Way; E. Langer, Genetic Engineering News, October 15, 2010
Downstream Disposables: The Missing Link in the Disposables Chain: Acceptance in has been slow.; E. Langer, BioPharm International, August 1, 2010
Project Managers Wanted: Relationship management is a limiting factor to growth in biomanufacturing outsourcing; E. Langer, Pharmaceutical Technology, Aug 2, 2010
Perfusion Bioreactors Are Making a Comeback, But Industry Misperceptions Persist; E. Langer, BioProcessing Journal, Summer 2010
Managing the Client-Contractor Relationship Increased bio/pharmaceutical outsourcing demands new management skills; E. Langer, Chimica Oggi / CHEMISTRY TODAY – vol 28 n 4 – July/August 2010
Bio/pharma outsourcing: Strategic initiative, or just passing off low-end jobs; E. Langer, Chemical Week; July 2010
Will Protein A Be the Long-Term Solution for Your Purification Needs? Cost-effective purification technologies.; E. Langer, BioPharm International, June 2010
As Biopharma Matures: Working Harder, Getting Leaner; E. Langer, Pharmaceutical Manufacturing, April 28, 2010
Biopharma Outsourcing Trends: Client-contractor relationships grow more complex; E. Langer, Contract Pharma, April 2010
Waste Not, Want Not: Restructuring in the biopharmaceutical industry is renewing a focus on resource optimization; E. Langer, Pharmaceutical Technology, April 2, 2010
Downstream Processing: Promising Technologies are on the Horizon; Beyond traditional chromatography; E. Langer, BioPharm International, March 2010
Contract Manufacturing Bucks Economic Downturn: Practitioners Cite Depth of Experience and Formation of a More Mature and Stable Business Model; E. Langer, Genetic Engineering News, February 2010
Single-Use Technology in Biopharmaceutical Manufacture, part 1; Brian Lee, Eric Langer, Ran Zheng, Wylie, Book Chapter, February 2010
On the Horizon: New Expression Systems to Become Common Industry Platforms; E. Langer, Biopharm International (June 2009)
Trends in Single-use Bioproduction; E. Langer, BioProcess International (April 2009)
Expanding Expression: Beyond CHO, E coli and Yeast; E. Langer, EBR-European Biopharmaceutical Review (April 2009)
Biopharmaceutical Products in US and European Markets, 5th Edition; Ron Rader, BioPlan Associates, Inc, July 2006
Capacity Bottleneck Squeezed by Downstream Processes; E Langer, J Ranck, BioProcess International, March 2006
The ROI Case: Economic Justification for Disposables in Biopharmaceutical Manufacturing; Eric S. Langer, J. Ranck, BioProcess International, October 2005
Biopharmaceutical Manufacturing: No single approach will resolve cost issues.; Genetic Engineering News, November 15, 2004
Big Shifts in Outsourcing of Biopharmaceutical Manufacturing—Half of Manufacturers to Outsource production by 2008; Genetic Engineering News, January 15, 2004
Gene Therapy–Dreams of Vectors in a Bottle; Genetic Engineering News, vol 17, no. 3, (February 1, 1997) pp. 8, 34
Pivotal Trial of Artificial Skin Advances Tissue Engineering Industry; Genetic Engineering News, volume 16, no. 2, (January 15, 1996) pp. 25
NIH Scientists Develop a Range of New Technologies for Tech Transfer; Genetic Engineering News, volume 14, no. 20, (May 15, 1992) pp. 7, 25
White Papers
The following aggregated White Papers are available by e-mail.
September BioPhorum COVID White Paper Sept 2022 [PDF]
Trends in Single-Use Bioprocessing 2D Bags Analysis March 2015 [PDF]
Novel Benchtop-Scale Single-Use Bioreactor: Attributes Assessment June 2014 [PDF]
Life Sciences Training and Education
Commercializing Life Sciences
E-mail BioPlan Associates to request purchase information
Training Needs in Biopharmaceutical Manufacturing
E-mail BioPlan Associates to request purchase information
Value of ROI in Life Sciences Marketing
E-mail BioPlan Associates to request purchase information
Newsletters
We offer the following free Newsletters for our subscribers.
BioFacilities News – Free, quarterly newsletter tracking news/trends in the biologics industry. 100s of sources filtered by our analysts’ 20+ years experience. Click here to receive a copy.
For the full version of our BioFacilities Newsletter, click here for more information about becoming a subscriber to our Top1000 Bio Database. Yearly subscriptions include the full quarterly newsletter.
BioChina News – Free, quarterly newsletter tracking news/trends in the China biopharmaceutical /pharmaceutical industry. Click here to receive a copy.
Click here for more information about becoming a subscriber to our Top100 China Directory Database. Yearly subscriptions available.
Publications and Reports
BioPlan Associates, Inc. delivers Biotech and Life Science Business Strategy Research and Analysis so our clients can make smarter, more effective business decisions. Our extensive market reports and publications cover biotechnology and biopharmaceutical manufacturing trends and insights, clinical trials, China CDMO and distributor growth, India biopharmaceutical market growth, and much more!
The following is our list of Publications and Reports.
Advances in Biopharmaceutical Technology in China, 2nd ed.
Advances in Biopharmaceutical Technology in India
Advances in Large Scale Biopharmaceutical Manufacturing
Biomanufacturing Manufacturing Capacity and Production, 2026
China Biomanufacturing Comparative Analysis
Quick Guide to Clinical Trials, 2nd ed.
Growth of Biopharmaceutical Contract Manufacturing Organizations in China
China Top Biopharmaceutical Manufacturing Directory, 2nd Ed.
Biopharmaceutical Expression Systems and Genetic Engineering Techniques
Quick Guide to Healthcare and Biotechnology in the Middle East
India Top 60 Biopharmaceutical Manufacturers
Top 60 Distributors of Bioprocessing Supplies in China
Webcasts
Drug Digest: Changes and Trends in the Outsourcing Landscape (2024)
In this episode of Drug Digest, Eric S. Langer, president and managing partner, BioPlan Associates discusses the current outsourcing landscape in the post-COVID world and the changes the pandemic has enforced in the demand for outsourced bioprocessing services.
Discovery Matters Podcast with CPhI (2021)
Dodi Axelson, Discovery Matters Podcast with CPhI talks with Eric Langer, Managing Partner of BioPlan Associates, about BioPlan’s Annual Report on Biopharmaceutical Manufacturing Capacity and Production.
China’s Emergence in Global Biopharma Manufacturing: Trends in the Chinese Biopharma Series (2018)
This four-part educational series, sponsored by BioProcess International and BioPlan Associates, Inc., highlights key trends emerging in China biopharmaceuticals, using select content from BioPlan Associates’ 2018 2nd edition report, Advances in Biopharmaceutical Technology in China, 2nd Ed., a unique, peer-reviewed study that incorporates the research and work from over 100 global industry expert authors, many based in China.
China Biopharma Opportunities – Watch Now
In Part 1, Michael Frizberg, President, CMAB – Switzerland and Hong Kong, highlights key drivers and areas of growth in China biopharma today, as well as cover areas of opportunities for expansion and revenue in today’s markets.
China Biopharma – A Hot Bed for Investments – Watch Now
In Part 2, Dr. Linda Pullan, Principal, Pullan Consulting, covers China investments, as well as advice for negotiating China deals.
China’s GMP Strategies: Dealing with Quality Management Issues – Watch Now
In Part 3, Fai Poon, President, QuaCell Biotech, Ltd., covers China regulatory issues, a review of current challenges in biopharma quality management in China, and opportunities for progress with growing CMO platforms and emerging CQO business.
Bioprocessing Challenges and CMO Opportunities – Watch Now
In Part 4, Dr. Scott Wheelwright, Co-Founder and Principal, Complya Asia, provides an overview of factors affecting manufacturing, manufacturing trends by market, biopharmaceutical manufacturing in China among CMOs and developing companies.
Continuous Processing: Technologies, Strategies, and Expertise for Process Intensification – BioProcess International, Renaud Jacquemart, March 2026
Media Optimization Strategies To Bring Down Costs: 36% of Facilities Want Better Supplements for Increased Titer in Bioprocessing – BioProcess International, Katrina Cordovado, May 2026
eBook: Biomanufacturing Capacity — Getting Creative in Complicated Global Markets – BioProcess International, Katrina Cordovado, Smita Khanna, Vicky Xia, June 2026
Single-Use Comes of Age—What’s Next? – Genetic Engineering News, Frances Lasowski and Renaud Jacquemart, August 2026
CDMO Capacity Crunch Persists – Contract Pharma, Katrina Cordovado, August 2026
Continuous Biomanufacturing and Perfusion Technologies Are Finally on the Cusp of Broad Adoption – BioProcess International, August 2026
Fill-Finish Contract Manufacturing for Biologics and Vaccines – Contract Pharma, Eric Langer, March 2025.
Outsourcing Hits Record Levels for All Bioprocess Platforms – Outsourced Pharma, Yasmin Timol, Ph.D., July 2025.
Biopharma Manufacturing Outsourcing Is Flexible, Not Fractured – Outsourced Pharma, Louis Garguilo, August 2025.
Report: Nearly 40% Of Biomanufacturers Eyeing Continuous Processing – BioProcess Online & Outsourced Pharma, Yasmin Timol, Ph.D., August 2025.
Single-Use Technologies: As Demand Rises, Tolerance for High Prices Falls – BioProcessing International, Yasmin Timol, Ph.D. August 2025.
eBook: Bioproduction Capacity — Continual Expansion To Meet Increasing Demands – BioProcessing International, Yasmin Timol, Ph.D., September 2025.
BioPharma By the Numbers: Rise of Bioprocessing Automation – BioPharm International, Eric Langer, September 2025.
BioPharma By the Numbers: Bioprocess Hiring Creating Capacity Constraints – BioPharm International, Eric Langer, October 2025.
Biomanufacturers Face Political and Staffing Headwinds – BioProcess International, Renaud Jacquemart, Ph.D., November 2025
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing – BioPharm International, Eric Langer, December 2025.
Survey: SUS Insufficient For 40% Of Biopharma – BioPharm International, Katrina Cordovado, December 2025.
21 New Downstream Technologies Being Considered To Fix Capacity Problems – BioProcess Online, BioPlan Staff, January 2024.
Continuous Manufacturing: Many Want It, But Here’s Why Few Have It – BioProcess Online, Ioanna Deni, February 2024.
Report: Single-use Bioreactor Uptake Plateaued, Other SUT On The Rise – BioProcess Online, Ioanna Deni, August 2024.
Wish SUS Cost Less? Survey Says Your Peers Do, Too – BioProcess Online, Ioanna Deni, September 2024.
Embracing single-use innovations in a post-COVID era – Pharma Manufacturing, Ioanna Deni, September 2024.
Post-COVID Trends in Biopharma Contract Manufacturing – Contract Pharma, Ioanna Deni, September 2024.
Top 50 Biopharma Products Drive Growth in Contract Manufacturing – Contract Pharma, Dr. Smita Khanna, October 2024.
Survey Says Downstream Biomanufacturing Bottleneck Is Over – BioProcess Online, Ioanna Deni, October 2024.
The Waiting Game: A Bottom Is Imminent For Bioprocessing In China With A Return To Growth Two Years Away – CPhI Online Trends, Vicky Q. Xia, October 2024.
Great Majority of Biomanufacturers to Outsource More Production Over the Next Five Years – CPhI Online Trends, Ioanna Deni, October 2024.
Biopharmaceutical Manufacturing Growth – Pharmaceutical Technology, Shriya Bhatkhande, February 2023.
Single-Use Bioprocessing Technologies Enabling More Rapid Vaccines Production – American Pharmaceutical Review, Shriya Bhatkhande, April 2023.
Demand Surges for Cell and Gene Therapy Contract Manufacturing – Contract Pharma, Arvind S. Deol and Eric S. Langer, May 2023.
Post-COVID Supply-Chain Challenges Are Easing, Part 1: New Competition Is Changing Industry’s Buying Behavior – BioProcess International, Eric Langer and Bob Brooks, BioPhorum, June 2023.
Post-COVID Supply-Chain Challenges Are Easing, Part 2: Impact of Increased Vendor Competition on Pricing – BioProcess International, Eric Langer and Bob Brooks, BioPhorum, August 2023.
Staffing Shortages: Major Hurdle for Bioprocess Contract Manufacturing Services in 2023 – BioPharm International, Shriya Bhatkhande, August 2023.
Survey Results Show What Could Finally Make Sustainability Stick – BioProcess Online, Doug Nissinoff, September 2023.
CPHI report: China develops own biologics niche; no longer low-cost manufacturer – Bioprocess International, Vicky Xia, September 2023.
Symbiotic Success: How CDMOs Shaped a Decade of Biomanufacturing – Contract Pharma, Doug Nissinoff, October 2023.
Here’s Why Outsourcing To CDMOs Doubled In 13 Years – BioProcess Online, Erica Friedman, October 2023.
Modular And Single-use Tech Driving The Future Of Biomanufacturing – BioProcess Online, Erica Friedman, November 2023.
Top 50 Biopharma Products Drive Growth in Contract Manufacturing – Contract Pharma, Arvind S. Deol and Dr. Smita Khanna, November 2023.
Top Biomanufacturing Trends for 2022 – DCAT, Joel Ranck, January 2022
2021’s Bioprocessing Year In Review & 7 Key Takeaways – DCAT, Dr. Smita Khanna, January 2022
The Single-use Bioprocessing Bottleneck & Looking Ahead – BioProcess Online, Dr. Paul Spencer, April 2022
Biopharma In China: The Emerging Global Force Of Domestic Suppliers – BioProcess Online, Vicky Xia and Leo Yang, May 2022
Contract Manufacturing During COVID: Biologics revenue increases 29%, but will this growth be sustainable? – Contract Pharma, Eric Langer, May 2022
2022 Outsourcing Trends In Biopharmaceutical Manufacturing – BioProcess Online, Dr. Smita Khanna, June 2022
Bioprocessing Sees Continued Improvements In Batch Failure Reductions In 2022 – BioProcess Online, Joel Ranck, July 2022
BioPlan report: Buoyant bioprocess space will continue to shine post-COVID – BioProcess International, Dan Stanton, October 2022
Cell and Gene Therapy Contract Manufacturers Are Critical to Industry Success – Contract Pharma, Joel Ranck, September 2022
Will China become an innovation hub? CPHI Annual Report 2022 highlights four key trends in China’s emerging innovative biopharma industry – Pharmaceutical Manufacturing, Vicky Xia, October 2022
The Biopharmaceutical Industry and Bioprocessing: What to Expect in 2021 – DCAT, Ronald A. Rader and Eric S. Langer, January 2021
Top Trends in Biomanufacturing 2020 – BioProcess International, Ronald Rader, February 2021
Economics of Perfusion Culture Media and Upstream Processing – American Pharmaceutical Review, Ronald Rader, Eric Langer, February, 2021
Worldwide Biopharmaceutical CMO Capacity Analysis – BioProcess International, Ronald Rader and Eric Langer, February 2021
The “New Normal”: Changing Perceptions on Bioprocess Intensification and Continuous Bioprocessing – BioProcess Online, Ronald A. Rader, March 2021.
Supply Chain Challenges Creating Hurdles to COVID-19 Vaccine Production [PDF] – BioPharm International, Jonathan S. Dakin, April 2021
Cell & Gene Therapy Bioprocessing: Demand For Better Process Control, Expertise & CMOs – BioProcess Online, Ronald Rader and Eric Langer, May 2021
Trends Affecting Biopharmaceutical Manufacturing – BioPharm International, David Lin, September 2021
Biopharma outsourcing goes international – Pharma Manufacturing, David Lin, October 2021
COVID-19 Spurs Growth Of China’s Domestic Bioprocessing Suppliers – BioProcess Online, Vicky Xia and Leo Yang, October 2021
2019 FDA Biopharmaceutical Approvals WP (published Jan 2020), Ronald Rader
Biosimilar Pipeline Experiencing 12% Annual Growth: A Progress Update – BioProcess Online, Ronald Rader, March 2020
Covid 19: Impact on Bioprocessing and Outsourcing – Contract Pharma, Ronald Rader and Eric Langer, May 2020
Biomanufacturing: Demand for Continuous Bioprocessing Increasing – Pharmaceutical Technology/BioPharm International, Eric Langer, June 2020
Cell And Gene Therapy Bioprocessing: Hiring And Capacity Crunch On The Horizon – BioProcess Online, Eric Langer June 2020
Culture Media Market Growth Drives Demand For New & Better Technologies – BioProcess Online, Kamna Jhamb, Ph.D., July 2020
COVID-19’s Impact On Bioprocessing: Insights From Industry Leaders – BioProcess Online, Ronald A. Rader, Eric S. Langer, and Kamna Jhamb, Ph.D, August 2020
Finding a Committed Bioprocess Supply Distributor in China: Managing Distributors in a Rapidly Growing Market – Genetic Engineering News, Vicky Xia and Leo Yang, September 2020
Samsung’s Drugmaking Future Includes a $2 Billion ‘Super Plant’ Bigger Than the Louvre – Wall Street Journal, Featuring quote from Eric S. Langer, Sept 2020
Cellular and Gene Therapies Face a Manufacturing Capacity Crunch – Pharmaceutical Technology/BioPharm International, Ronald Rader, September 2020
CONTINUOUS BIOPROCESSING: WHEN WILL WE SEE COMMERCIAL SCALE OPERATIONS? – Teknoscienze and ChemOutsourcing, Ronald Rader, October 2020
Biopharma trends accelerate: The pandemic has amplified the industry’s hiring problems and growth – Pharmaceutical Manfacturing, Ronald Rader, October 2020
Accelerating Trends in Bioprocessing COVID-19 Crisis Intensifies Need for Collaborative Solutions – American Pharmaceutical Review, Ronald A. Rader, Eric S. Langer, and Kamna Jhamb, Ph.D, October 2020
Biologics Manufacturing In China: Competition Heats Up Among CMOs & Their Clients – BioProcess Online, Vicky Xia and Leo Yang, October 2020
Global trends and growth opportunities in the biopharmaceutical product development and manufacturing – CPhI, Eric Langer, October 2020
Growth of Domestic Mab Pipeline, Regulatory Reform and New Investment is changing the landscape of Biologics CDMOs in China – CPhI, Vicky Xia and Leo Yang, October 2020
Cell and Gene Therapies: Challenges in Scale-up to Commercial Manufacturing – Results Healthcare, Ronald Rader, December 2020
Bioprocessing Year In Review: 11 Key Trends Accelerated By COVID-19 – BioProcess Online, Ronald Rader and Eric Langer, December 2020
Biomanufacturing Capacity and Supplies: COVID’s Impact – DCAT, Ronald Rader and Eric Langer, December 2020
The Outlook for CMO Outsourcing in 2019 – BioPharm International, Jan 2019, Ronald Rader and E. Langer
Worldwide Biopharmaceutical CMO Capacity Analysis – Feb 2019, BioProcess International, Ronald Rader and E. Langer
Part 2 – Can China Become a Top Destination for Biologics Manufacturing? – Market Research Blog, Feb 18, 2019, Eric Langer
China Can Be Ignored No Longer: Long-Term Biopharmaceutical Opportunities Based on Near-Term Demonstrated Growth – BioProcess International, March 2019, Vicky (Qing) Xia and E. Langer
Biosimilars Set to Further Expand the Biopharmaceutical Market – American Pharmaceutical Review, March 2019, Ronald Rader and E. Langer
CMOs Leading the Way on Single-Use Systems Adoption – Pharmaceutical Technology, March 2019, Ilene Roizman and E. Langer
Biosimilars Pipeline Shows Remarkable, Sustained Growth – BioProcess Online, March 2019, Ronald Rader
Disposables/Single-Use Roundtable – American Pharmaceutical Review, March 2019, Eric Langer
Bioprocessing Facilities and FDA Inspection Problems – BioPharm International/Pharmaceutical Technology, May 2019, Ronald A. Rader
China Looks Inward and Outward: Investments in US and EU Biopharmaceutical Companies Are on the Rise – BioProcess International, May 2019, Vicky Xia and Eric S. Langer
Trends In Single-Use System Adoption In The Biopharma Industry – BioProcess Online, June 2019, Ilene Roizman
Good Manufacturing Practice in China: Equipment Strategy and Quality Management to Compete with the West – BioProcess International, June 2019, Vicky Xia
Outsourcing in China: How far can it go? – Contract Pharma, July 2019, Vicky Xia
Asia Bioprocessing Capacity Trends: Overall Growth, But Cell Therapy Shortages Loom – BioProcess Online, August 2019, Vicky Xia
Trends To Watch In China’s Biopharma Industry – BioProcess Online, October 2019, Vicky Xia
China’s single-use craze – Pharma Manufacturing, October 2019, Vicky Xia
Trends in Biopharma Contract Manufacturing in China and India – CPhI, November 2019, Vicky Qing Xia & Ronald A. Rader
Biopharma Over 20 Years – Contract Pharma, K. John Morrow, Jr. and E. Langer, November 2019
The next decade of cleanrooms – Pharmaceutical Manufacturing, Ronald A. Rader, December 2019
Biopharma Year in Review – Looking Ahead to 2020 – Pharmaceutical Online/BioProcess Online, December 2019, K. John Morrow Jr. and E. Langer
Biosimilars on Cusp of Far-Reaching Impact; BioCompare; January 2018, Ronald A. Rader
Current Challenges in Bioprocesses Development; Pharmaceutical Technology; March 2018, Ronald A. Rader
CMOs & Biosimilars Mfg. in the U.S.; Contract Pharma; April 2018, Eric S. Langer and Ronald A. Rader
Contract Biomanufacturing in China: Creating a New Segment; Contract Pharma; April 2018, Vicky Xia and Leo Yang.
eBook: The Commercial Expression Systems Market — What Has Changed in the Past Decade; BioProcess International; May 2018, R. Rader
Demand for Capacity Drives China’s Biomanufacturing Expansion; BioProcess International; June 2018, Vicky Qing Xia and Leo Cai Yang
Fifteen Years of Progress: Biopharmaceutical Industry Survey Results; BioPharm International; July 2018, R. Rader
Biopharmaceutical Manufacturing is Shifting to Single-Use Systems. Are the Dinosaurs, the Large Stainless Steel Facilities, Becoming Extinct?;American Pharmaceutical Review; October 2018, E. Langer.
Top 12 Biopharma Manufacturing Trends; Genetic Engineering News; October 2018, E. Langer.
Improving Training in Biopharmaceutical Manufacturing; BioProcess Online; October 2018, I. Roizman and E. Langer.
7 Reasons There Was Never Going To Be A Bioprocessing Capacity Crunch; Outsourced Pharma; October 2018, Louis Garguilo (interview with R. Rader and E. Langer).
eBook: Biopharma Manufacturing Markets: Biomanufacturing contract services and supplies markets continues to expand; Contract Pharma; November 2018, R. Rader and E. Langer.
Staffing shortage leaving blockbuster biologics undeveloped, says expert; BioProcess International; November 2018, Dan Stanton (interview with E. Langer).
eBook: Single-Use Bioprocessing Equipment Trends and Adoption by CMOs; Pharmaceutical Technology; November 2018, R. Rader and E. Langer.
Part 1 – China Biopharmaceutical Growth Exceeding Western Projections – Market Research Blog, Nov 28, 2018, Eric Langer
Top Trends In The Biopharmaceutical Industry And Bioprocessing For 2019; BioProcess Online; December 2018, R. Rader and E. Langer.
Overcoming The Manufacturing Hurdles Of Cell & Gene Therapy; BioProcess Online; February 2017, R. Rader
Modular Bioprocess Facilities Expanding Capacity in China; Genetic Engineering News; March 2017, V. Xia
CMOs Hiring Constraints: Cell Therapy Manufacturing Expecting Future Challenges; Contract Pharma; March 2017, E. Langer
Biosimilar Markets and Regulation: Which Countries Are Going All In?; BioProcess International; April 2017; R Rader
Staffing for China’s Rapidly Growing Biomanufacturing Industry; Pharmaceutical Technology; April 2017, V. Xia
CMOs & Biosimilars Mfg. in the U.S.; Contract Pharma; April 2017, E. Langer and R. Rader
Trends in Bioprocess Automation: Quality Control and Process Analytical Technology in High Demand; BioProcessing Journal; Spring 2017, K. Estes and E. Langer
Driving Bioprocessing Efficiency; Pharmaceutical Manufacturing; May 2017, K. Estes and E. Langer
China Biopharma: Is a Wave of GMP Exports in Our Future?; PharmaFocus Asia; May 2017, V. Xia, L. Yang, E. Langer
Update on Continuous Bioprocessing: From the Industry’s Perception to Reality; Pharmaceutical Technology; June 2017, K. Estes and E. Langer
Chinese And Indian GMP Biologics Exports: Surveying The Current Landscape; BioProcess Online; June 2017, V. Xia, L. Yang, E. Langer
Trends in New Technologies & Budgets; Contract Pharma; June 2017, E. Langer
Trends in Biopharma Contract Manufacturing in China and India; Pharmaceutical Outsourcing; June 2017, V. Xia and R. Rader
2 part series – Chinese & Indian Expectations For GMP Biologics Exports — A Comparative Assessment; BioProcess Online; July 2017, V. Xia, L. Yang, E. Langer
Current Trends in Analytical Testing; Contract Pharma; May 2017, E. Langer
Biosimilars Paving The Way For Cost-Effective Bioprocessing; BioProcess Online; August 2017, R. Rader and E. Langer
Outsourcing Trends in Biopharmaceutical Manufacturing; Pharmaceutical Outsourcing; September 2017, E. Langer
Trends and Growth in Single-Use System (SUS) Adoption; American Pharmaceutical Review; October 2017, E. Langer
Downstream Gears Up; Pharmaceutical Manufacturing; November 2017, E. Langer
Cell and Gene Therapies: Industry Faces Potential Capacity Shortages; Genetic Engineering News; November 2017, Ronald Rader
Hiring and Staffing in Biopharmaceutical Manufacturing: Five-Year Trends Indicate Difficulty in Filling Positions; Bioprocess International; January 2016; E. Langer
Alternatives to Protein A: Who’s Investigating?; Genetic Engineering News; February 2016, E. Langer
New Technologies for Fill-Finish; CMOs Are Well Positioned as Early Adopters; Genetic Engineering News; February 2016, E. Langer
Taking Stock of Biopharma’s Outsourcing Markets; Contract Pharma; February 2016, E. Langer
CMOs Step Up in Areas Where BioPharma is Short-Staffed; Pharmaceutical Outsourcing; March 2016, E. Langer
What’s Holding Back Single-Use Adoption?; Pharmaceutical Processing; March 2016, E. Langer
4 Key Trends In Biopharmaceutical Manufacturing In 2016; BioProcess Online; April 2016, E. Langer
Future Manufacturing Strategies for Biosimilars; BioProcess International; May 2016, R. Rader and E. Langer
Outsourcing of Biomanufacturing in 2016; Pharmaceutical Technology; May 2016, E. Langer
Biosimilars Segment—A Fast-Moving Blur; Genetic Engineering News; June 2016, E. Langer
Biomanufacturing Outsourcing Budgets Grow, Slowly; Pharmaceutical Technology; June 2016, E. Langer
Microbial Platforms Set for Rapid Growth; Genetic Engineering News; July 2016, E. Langer
Contract Manufacturing Budget Trends: Study shows where the money is, and isn’t, flowing; Contract Pharma; July 2016, E. Langer
Biosimilars Pipeline Analysis: Many Products, More Competition Coming; BioProcess Online; July 2016, R. Rader
CMOs and Innovation; Pharmaceutical Outsourcing; August 2016, E. Langer
Hiring Difficulties Compound Downstream Processing Woes; Genetic Engineering News; September 2016, E. Langer
Economics of In-House Buffer Preparation: Evaluating the cost effectiveness of keeping basic ops in-house; Contract Pharma; September 2016, E. Langer
Biopharmaceutical Manufacturing Globalization Continues; Pharmaceutical Outsourcing; September 2016, E. Langer
Average Batch Failure Rate Worsens; Genetic Engineering News; October 2016, E. Langer
Fill/Finish Outsourcing: This key bioprocessing segment is expecting continued growth; Pharmaceutical Technology; October 2016, E. Langer
Continuous Bioprocessing Overtakes Single-Use On List Of Top Technology Trends; BioProcess Online; October 2016, E. Langer
Year-End Trends in Biopharma Contract Manufacturing; Contract Pharma; November 2016, E. Langer
Manufacturing Costs Will Be Critical to Biosimilars’ Success; Pharmaceutical Manufacturing; November 2016, R. Rader
Biopharmaceutical Manufacturing Growing Rapidly in China; Genetic Engineering News; December 2016, E. Langer
Biosimilars Supporting Contract Manufacturers’ Growth: Biosimilars may be the key to CMO growth; Pharmaceutical Technology; December 2016, E. Langer
2017 Biopharmaceutical Trends — Opportunities For The New Year; BioProcess Online; December 2016, E. Langer
Fill/Finish Capacity Use for Biologics; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; January 2015, E. Langer
Biosimilars Impacting CMO Capacity; Pharmaceutical Outsourcing; February 2015; E. Langer
7 Top Trends in Biomanufacturing Outsourcing; Contract Pharma; January 2015; E. Langer and J.C. Lupis
CMO’s Plan for Capacity Expansions; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; March 2015, E. Langer
30 Years of Upstream Productivity Improvements; BioProcess International; February 2015; R. Rader and E. Langer
A Fully Disposable Bioprocessing Facility: Is it on the horizon?; Pharma IQ; February 2015; E. Langer
Outsourcing Budgets Continue to Shine: Preliminary study data indicates continued spending on outsourcing; Contract Pharma; April 2015, E. Langer
Biomanufacturing Outsourcing Globalization Continues; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; May 2015; E. Langer
Leachables And Extractables In Single-Use: Trends and Expectations Over Plastics Innovation; BioProcess Online, LSL; March 2015; E. Langer
Biosimilars Improving Efficiency, Cost for All Biologics; Contract Pharma; April 2015, E. Langer
BioPharma Industry Seeks Downstream Processing Advances; Pharmaceutical Processing; June 2015; E. Langer
Another In-House Operation Gets Outsourced; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; June 2015; E. Langer
Key Trends Shaping Fill/Finish Operations From Single-Use Adoption to CMO Acquisitions— Trends to Watch for This Year; American Pharmaceutical Review/Pharmaceutical Outsourcing; May 2015; E. Langer
Critical Trends Driving BioManufacturing Production Strategies; Pharmaceutical Manufacturing; June 2015; E. Langer
CMOs Demanding Easier-to-Integrate Single-use Devices; Contract Pharma; May 2015; E. Langer and J.C. Lupis
Single-Use Standardization: Is It Holding Back The Biopharma Industry?; BioProcess Online, LSL; June 2015; E. Langer
Hiring in Biopharma: Rapid Industry Growth is Creating Bottlenecks; Pharmaceutical Processing; July 2015; E. Langer
Getting to Yes; Contract Pharma; July 2015; E. Langer
New Technologies for Downstream Efficiencies; Pharmaceutical Manufacturing; June 2015; E. Langer
Outsourcing Becoming More Cost Competitive; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; August 2015; E. Langer
Is Biopharma Ready to Say Goodbye to Batches?; Medicine Maker; August 2015; E. Langer
CMOs Concerned With Cost of Single-Use Equipment; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; September 2015; E. Langer
CMOs Are Willing to Pay for More Innovation; Contract Pharma; September 2015; E. Langer
Bio Pharma Manufacturing’s Top 15 Trends for 2015; Pharmaceutical Manufacturing; August 2015; E. Langer and J.C. Lupis
Globalization Hits Biopharma Contract Manufacturing; Contract Pharma; October 2015; E. Langer
Advances in Bioprocessing: Single-Use and Stainless Steel Technologies; BioProcessing International; December 2015; E. Langer
Biopharmaceutical Manufacturing: Historical and Future Trends in Titers, Yields, and Efficiency in Commercial-Scale Bioprocessing; BioProcessing Journal; Winter 2015; R. Rader and E. Langer
Are CMOs Really Going to See a Capacity Pinch?; Genetic Engineering News; November 2015; E. Langer
2015 in Review: 6 Key Trends Affecting CMOs; Contract Pharma; November 2015; E. Langer
Continuous Bioprocessing in Operation; Genetic Engineering News; December 2015; E. Langer
Cell Culture Media Process Optimization; Genetic Engineering News; December 2015, E. Langer
Regulatory Concerns For Facilities Of The Future: Does Flexibility Come With A Cost?; BioProcess Online, LSL; December 2015; E. Langer
Year in Review: Key Outsourcing Trends to Watch This Year; Pharmaceutical Outsourcing, January 2014; E. Langer
Novel Expression Systems Opening CMO Opportunities; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, January 2014; E. Langer
Who’s Improving Bioprocessing In 2014; Life Science Leader, January 2014; E. Langer
Continuous Bioprocessing and Perfusion: Wider Adoption Coming as Bioprocessing Matures; BioProcessing Journal, Spring 2014; E. Langer
Outsourcing trends in Biopharmaceutical Manufacturing; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, February 2014; E. Langer
Single Use Technologies in Biopharmaceutical Manufacturing: A 10-year Review of Trends and the Future; Engineering in Life Sciences, May 2014; E. Langer
Too Much CMO Capacity? Biomanufacturers plan their 2018 capacity expansions; Contract Pharma, March 2014; E. Langer
Best Practices in Biomanufacturing Supplier Relations: Reducing Raw Materials Risks; Life Science Leader; February 2014; E. Langer
Bioprocess Advances Drive Vaccine Manufacturing in Developing Countries; BioProcess International, February 2014; E. Langer and R. Rader
Innovation Is This Year’s Magic Wand; Genetic Engineering News, March 2014; E. Langer
Powders and Bulk Liquids; Bioprocess International, March 2014; E. Langer and R. Rader
Innovation in Pre-packed Disposable Chromatography Columns; BioPharm International Supplement, March 2014; E. Langer
Manufacturers Open Their Wallets for Outsourcing: Accessing Technical Expertise and Cutting Costs; BioProcess International, April 2014; E. Langer
Biopharma Quality Management Best Practices: An Approach to Quality Initiatives; Life Science Leader, April 2014; E. Langer
Outsourcing No Longer Just for Cost-Cutting; Pharmaceutical Technology, May 2014; E. Langer
CMOs Most Critical to Success Factors; Pharmaceutical Processing, April 2014; E. Langer
Bioprocessors Demanding Single-Use Sensors Best Practices; Life Science Leader, May 2014; E. Langer
Bioprocessing Trends to Expect in 2014; Genetic Engineering News, June 2014; E. Langer
Bio/Pharma Industry Improves Downstream Operations Best Practices: Membrane Technology Options; Life Science Leader, July 2014; E. Langer
BioPharma Unhappy With Suppliers’ Progress on Single-Use Hookups; BioProcess International, September 2014; E. Langer
Biopharm Executives Point to Better CMO Performance; Contract Pharma, October 2014; E. Langer
Outsourcing Grows in Europe; Pharmaceutical Technology Europe, August 2014; E. Langer
Outsourcing Media and Buffer Prep; Contract Pharma, September 2014; E. Langer
Targeting Different Offshore Destinations; Pharmaceutical Technology, September 2014; E. Langer
Outsourcing Economic Models Are Changing; Life Science Leader, September 2014; E. Langer
Moving Beyond the Batch: Best Practices, Opportunities and Challenges in Continuous Bioprocessing; Life Science Leader, October 2014; E. Langer
Bioprocessing Challenges of Antibody-Drug Conjugates; BioProcess International, October 2014; R. Rader
Budgets Increase to Support Single-Use Bioprocessing; BioPharm International, November 2014; E. Langer
Single-use Disposables are Future Proofing Biopharmaceutical Manufacturing; PharmaIQ, October 2014; E. Langer
The Biosimilars Opportunity: 4-years of Waiting; Life Science Leader, October 2014; E. Langer
Risks and Rewards in the U.S. BioSimilars Pipeline; Pharmaceutical Manufacturing, October 2014; E. Langer
The US Biosimilars Future Is Hard to Predict: Global Health Policy, Innovation, Prices, and Profits Are All at Stake; BioProcess International, December 2014
Biomanufacturing Industry Not Providing Employees the Tools to Succeed; Life Science Leader, November 2014; E. Langer
Year in Review: Trends in Biopharma Manufacturing Outsourcing; Pharmaceutical Technology, December 2014; E. Langer
Critical Innovation BioProcessing Trends For 2014; Life Science Leader, December 2013; E. Langer
Disposable Chromatography: Options Are Increasing Requirements for greater productivity and efficiency are moving interest toward disposable options; Genetic Engineering News, December 2013; E. Langer
Biopharmas Increasingly Satisfied With Vendors Of Single-Use Products; Life Science Leader, December 2013; E. Langer
Future proofing biopharmaceutical manufacturing: the industry seeks a leaner version of itself; Future Science, December 2013; E. Langer and R. Rader
CMOs Demanding More Innovations; Contract Pharma, November 2013
Innovation In Stainless-Steel Bioprocessing; Life Science Leader, October 2013; E. Langer and R. Rader
Seeking Innovation to Solve Persistent Problems; Pharmaceutical Manufacturing, November 2013; E. Langer
Bio-CMO Capacity Constraints; Contract Pharma, September 2013; E. Langer
Industry Adoption of Membrane Adsorbers; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, October 2013; E. Langer
Client Relationships: How CMOs Can Avoid The Pitfalls; Life Science Leader, October 2013; E. Langer
Innovation In Alternative Chromatography; Life Science Leader, October 2013; E. Langer
PAT Adoption Hurdles Remain; Pharmaceutical Manufacturing, October 2013; E. Langer
Making the Best of a Bad CMO-Client Relationship; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, September 2013; E. Langer
Innovation In Expression Systems Yields Increase Productivity; BioProcess Online, August 2013; E. Langer
Bioprocessing Advances in Vaccine Manufacture; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, September 2013; E. Langer and R. Rader
What Happened to Outsourcing in Asia?; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, August 2013; E. Langer
Innovation In Disposable Connectors; Life Science Leader, July 2013; E. Langer
Demand For Innovation In High-Value Bioprocessing; Life Science Leader, June 2013; E. Langer
Disposable Applications Penetrate Biomanufacturing Market; Pharmaceutical Manufacturing, June 2013; E. Langer
Keeping New Technologies Coming; BioProcess International, June 2013; E. Langer
Outsourcing’s Modest Role as a Cost-Containment Strategy; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, May 2013; E. Langer
CMOs Leading The Way In Biopharma Innovation – No Herd Mentality; Life Science Leader, May 2013; E. Langer
Outsourcing of Fill-Finish Operations Continues; Pharmaceutical Processing, April 2013; E. Langer
Global Changes in Biomanufacturing; A retrospective analysis of CMO Trends; Contract Pharma, April 2013, E. Langer
Single-use Bioprocessing Sensor Innovation Is In Need; Life Science Leader, April 2013; E. Langer
Vendors Ignore Calls For Innovation In Assays; Life Science Leader, April 2013; E. Langer
Biopharma Continues Globalization Efforts; Global Corporate Xpansion, April 2013; E. Langer
Focus on Efficiency: Single-use, analytical methods and downstream processing at the forefront.; Pharmaceutical Manufacturing, March 2013; E. Langer
Outsourcing of Non-traditional Protein Expression Systems Increases; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, April 2013; E. Langer
The Big Squeeze; European Biopharmaceutical Review, Spring 2013; E. Langer
Fill-Finish Innovation: Showing Sparks of Life; Contract Pharma, March 2013; E. Langer and R. Rader
Innovation In Assays And Analytical Methods Urgently Needed; Life Science Leader, February 2013; E. Langer
Biopharmas Increasingly Satisfied With Vendors Of Single-Use Products; Pharmaceutical Online, February 2013; E. Langer
The Future of BioPharma; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, February 2013; E. Langer
Offshoring Biomanufacturing; Pharmaceutical Technology, February 2013; E. Langer
Breaking the Biotech Bottleneck: Downstream capacity still lags behind upstream, but shortages are now “acute” rather than “chronic; Pharmaceutical Manufacturing, January 2013; E. Langer
Sponsors Look to Asia for Potential Contract Partners; BioProcessing International, January 2013; E. Langer
Biopharma Outsourcing Leveling Out; Pharmaceutical Online, August 2012, Eric Langer
Gauging Biopharm Outsourcing; Pharmaceutical Technology August 2012, Eric Langer
CMOs and Biodevelopers Taking Different Approaches to DSP Problems: CMOs Get Serious About New Technologies; E. Langer, Pharmaceutical Outsourcing, July 2012
Top 50 (or so) Biopharma Products: Ranking the top 57 biopharma products by 2011 revenues – Contract Pharma, Ronald Rader, July 2012
BioPharma Industry Gives the Nod to Single-Use Bioreactors; E. Langer, Genetic Engineering News, July 2012
Biomanufacturing Innovation; E. Langer, BioPharm International, July 2012
Biopharmas Increasingly Satisfied with Vendors of Single-Use Products; E. Langer, Life Science Leader, July 2012
Biomanufacturers Looking for Single-Use Innovations; E. Langer, Pharmaceutical Online, June 2012
Biomanufacturing Shows Signs of Maturity, PAT Adoption; E. Langer, June 2012
Biomanufacturing Innovation; E. Langer, Pharmaceutical Technology, June 2012
25 Years of Biopharma Industry Growth; E. Langer, BioPharm International, June 2012 Special Issue
Hiring In Biopharma — Where Are The Jobs Going Next?; E. Langer, Life Science Leader, May 2012
10 years of biomanufacturing: Industry maturity shown in the shifts toward process improvement; E. Langer, BioProcess International, May 2012
Single-Use Technologies Used Less for Downstream Purification Issues; E. Langer, Pharmaceutical Online, May 2012
Bio-Growth Slowing?; E. Langer, Contract Pharma, May 2012
Productivity Focus: CMOs Look to Get More From Their Employees; E. Langer, Genetic Engineering News, May 2012
BioManufacturers Increasing Budgets for New Technologies; Eric Langer, BIO, May 3, 2012
CMOs on the Hunt for Disposable Solutions; E. Langer, Pharmaceutical Processing, April 2012
BioPharma Industry Getting Comfortable with Complex Single Use Devices; E. Langer, Pharmaceutical Online, March 2012
Biopharma Vendor Satisfaction: Are Suppliers Doing What’s Best For The Industry?; E. Langer, Life Science Leader, March 2012
Industry Adopting More Complex Devices; E. Langer, Contract Pharma, March 2012
Pharmaceutical Outsourcing Trends: The Next Decade; E. Langer, BioPharm International, March 2012 Special Issue
Are Downstream Problems Finally Being Resolved?; E. Langer, BioProcess International, March 2012
Biosimilars and Biobetters; Eric Lanager, Pharmaceutical Processing, Feb 2012
Biomanufacturing Outlook; Eric Langer, Pharmaceutical Technology, Feb 2012
Biopharma Manufacturers Looking for Product Innovation; E. Langer, Life Science Leader, February 2012
Single Use Biomanufacturing Devices in High Demand; E. Langer, Pharmaceutical Online, February 2012
Upstream Single-Use Bioprocessing Systems; Ron Rader and Eric Langer, BioProcess International, February 2012
Biopharmaceutical Industry in 2012: Optimism on the Rise; E. Langer, Pharmaceutical Technology, February 2012
Biopharma Industry Enthusiastic About 2012; Eric Langer, BIO, January 12, 2012
Limited Analytical Technologies Are Inhibiting Industry Growth; E. Langer, October 2011
Top 1000 Global Biomanufacturing Facilities- Insights from real-time ranking of global biomanufacturing capabilities.; E. Langer, BioPharm International, August 2011
Can Outsourcing GMP Operations to China Really Work?; E. Langer, Life Science Leader, August 2011
Single Use Bioreactors Lead in New Use and Market Penetration; E. Langer, Pharma IQ, August 2011
Single Use Devices-Whats REALLY Holding Up Adoption?; E. Langer, Life Science Leader, July 2011
Positive Trends in Biomanufacturing Budgets: Biopharma and Vendor Budgets Are Up For the First Time in Three Years; E. Langer, BioProcessing Journal, July 2011
Hiring In Biopharma — Where Are The Jobs Going Next?; E. Langer, Life Science Leader, July 2011
Bio-Outsourcing On the Rise: Fewer companies go 100% in-house; E. Langer, Contract Pharma, June 2011
Will Perfusion Be the Next Revolution in Bioprocessing?; E. Langer, BioProcess International, June 2011
Offshoring Biomanufacturing: China rises to the top as a destination for international sourcing; E. Langer, BioProcess International, June 2011
Biomanufacturing Budget Bump-2011’s Spending Upswing; E. Langer, PharmaIQ, June 2011
Top 1000 Biomanufacturing Facilities: Knowing where key biomanufacturing facilities are located around the world is essential for decision-making.; E. Langer, BioPharm International, June 2011
Trends in Biopharmaceutical Industry: Budgets Returning…Investing In Innovation…Productivity & Cost Control; E. Langer, Pharmaceutical Manufacturing, June 2011
Biotech Budgets: Whose Departments Are Winning?; E. Langer, Life Science Leader, June 2011
Biopharma Wants Better Upstream Bioprocessing Technologies; E. Langer, Pharmaceutical Technology, May 2011
Downstream Process Bottlenecks: Industry Demanding Better Technologies; E. Langer, Genetic Engineering News, May 2011
Hiring Trends in Biopharma; E. Langer, Ashton Tweed, May 2011
Time to Build ‘Relationship’ into the Outsourcing Process; E. Langer (BioData Points), Life Science Leader, May 2011
Single Use Technologies Changing the Biomanufacturing Landscape; E. Langer, Life Science Leader, May 2011
Single Use Trends Boosting Adoption or Vendor Satisfaction; E. Langer, Pharmaceutical Manufacturing, May 2011
New Plant Expression Systems Drive Vaccine Innovation and Opportunity; E. Langer, BioProcess International, April 2011
Productivity Bottlenecks Drive the Demand for Innovation; E. Langer, BioProcess International, March 2011
Improved Downstream Technologies Are Needed to Boost Single-Use Adoption; E. Langer, BioProcess International, March 2011
Single-Use Products in BioManufacturing: Innovations Driving the Industry; E. Langer, BioProcess International, March 2011
Changes Underway for Biopharmaceutical Outsourcing More crucial biomanufacturing operations are expected to be outsourced
E Langer Presents 2011 Trends for Life Science Leader Journal; E. Langer, Life Science Leader Journal, January 2011
European Biomanufacturing Efficiency Outstripping US: Outlook for Capacity Utilisation Through 2015; E. Langer, European Biopharmaceutical Review, January 2011
Biofuels: Road to Recovery; D. Mousdale, BioFuels International, December 2010
Outsourcing Winners in 2014: Post recession and beyond; E. Langer, Pharmaceutical Technology, Nov 2, 2010
Trends to Watch in the Biopharmaceutical Industry; E. Langer, Pharmaceutical Executive, Supplement for Nov. 2010
Regulatory Challenges Impede Adoption of new Downstream Technologies; E. Langer, BioPharm International, October 2010
Plant Expression Systems Growing Rapidly, Vaccines Manufacturers Leading the Way; E. Langer, Genetic Engineering News, October 15, 2010
Downstream Disposables: The Missing Link in the Disposables Chain: Acceptance in has been slow.; E. Langer, BioPharm International, August 1, 2010
Project Managers Wanted: Relationship management is a limiting factor to growth in biomanufacturing outsourcing; E. Langer, Pharmaceutical Technology, Aug 2, 2010
Perfusion Bioreactors Are Making a Comeback, But Industry Misperceptions Persist; E. Langer, BioProcessing Journal, Summer 2010
Managing the Client-Contractor Relationship Increased bio/pharmaceutical outsourcing demands new management skills; E. Langer, Chimica Oggi / CHEMISTRY TODAY – vol 28 n 4 – July/August 2010
Bio/pharma outsourcing: Strategic initiative, or just passing off low-end jobs; E. Langer, Chemical Week; July 2010
Will Protein A Be the Long-Term Solution for Your Purification Needs? Cost-effective purification technologies.; E. Langer, BioPharm International, June 2010
As Biopharma Matures: Working Harder, Getting Leaner; E. Langer, Pharmaceutical Manufacturing, April 28, 2010
Biopharma Outsourcing Trends: Client-contractor relationships grow more complex; E. Langer, Contract Pharma, April 2010
Waste Not, Want Not: Restructuring in the biopharmaceutical industry is renewing a focus on resource optimization; E. Langer, Pharmaceutical Technology, April 2, 2010
Downstream Processing: Promising Technologies are on the Horizon; Beyond traditional chromatography; E. Langer, BioPharm International, March 2010
Contract Manufacturing Bucks Economic Downturn: Practitioners Cite Depth of Experience and Formation of a More Mature and Stable Business Model; E. Langer, Genetic Engineering News, February 2010
Single-Use Technology in Biopharmaceutical Manufacture, part 1; Brian Lee, Eric Langer, Ran Zheng, Wylie, Book Chapter, February 2010
On the Horizon: New Expression Systems to Become Common Industry Platforms; E. Langer, Biopharm International (June 2009)
Trends in Single-use Bioproduction; E. Langer, BioProcess International (April 2009)
Expanding Expression: Beyond CHO, E coli and Yeast; E. Langer, EBR-European Biopharmaceutical Review (April 2009)
Biopharmaceutical Products in US and European Markets, 5th Edition; Ron Rader, BioPlan Associates, Inc, July 2006
Capacity Bottleneck Squeezed by Downstream Processes; E Langer, J Ranck, BioProcess International, March 2006
The ROI Case: Economic Justification for Disposables in Biopharmaceutical Manufacturing; Eric S. Langer, J. Ranck, BioProcess International, October 2005
Biopharmaceutical Manufacturing: No single approach will resolve cost issues.; Genetic Engineering News, November 15, 2004
Big Shifts in Outsourcing of Biopharmaceutical Manufacturing—Half of Manufacturers to Outsource production by 2008; Genetic Engineering News, January 15, 2004
Gene Therapy–Dreams of Vectors in a Bottle; Genetic Engineering News, vol 17, no. 3, (February 1, 1997) pp. 8, 34
Pivotal Trial of Artificial Skin Advances Tissue Engineering Industry; Genetic Engineering News, volume 16, no. 2, (January 15, 1996) pp. 25
NIH Scientists Develop a Range of New Technologies for Tech Transfer; Genetic Engineering News, volume 14, no. 20, (May 15, 1992) pp. 7, 25
Continuous Processing: Technologies, Strategies, and Expertise for Process Intensification – BioProcess International, Renaud Jacquemart, March 2026
Media Optimization Strategies To Bring Down Costs: 36% of Facilities Want Better Supplements for Increased Titer in Bioprocessing – BioProcess International, Katrina Cordovado, May 2026
eBook: Biomanufacturing Capacity — Getting Creative in Complicated Global Markets – BioProcess International, Katrina Cordovado, Smita Khanna, Vicky Xia, June 2026
Single-Use Comes of Age—What’s Next? – Genetic Engineering News, Frances Lasowski and Renaud Jacquemart, August 2026
CDMO Capacity Crunch Persists – Contract Pharma, Katrina Cordovado, August 2026
Continuous Biomanufacturing and Perfusion Technologies Are Finally on the Cusp of Broad Adoption – BioProcess International, August 2026
Fill-Finish Contract Manufacturing for Biologics and Vaccines – Contract Pharma, Eric Langer, March 2025.
Outsourcing Hits Record Levels for All Bioprocess Platforms – Outsourced Pharma, Yasmin Timol, Ph.D., July 2025.
Biopharma Manufacturing Outsourcing Is Flexible, Not Fractured – Outsourced Pharma, Louis Garguilo, August 2025.
Report: Nearly 40% Of Biomanufacturers Eyeing Continuous Processing – BioProcess Online & Outsourced Pharma, Yasmin Timol, Ph.D., August 2025.
Single-Use Technologies: As Demand Rises, Tolerance for High Prices Falls – BioProcessing International, Yasmin Timol, Ph.D. August 2025.
eBook: Bioproduction Capacity — Continual Expansion To Meet Increasing Demands – BioProcessing International, Yasmin Timol, Ph.D., September 2025.
BioPharma By the Numbers: Rise of Bioprocessing Automation – BioPharm International, Eric Langer, September 2025.
BioPharma By the Numbers: Bioprocess Hiring Creating Capacity Constraints – BioPharm International, Eric Langer, October 2025.
Biomanufacturers Face Political and Staffing Headwinds – BioProcess International, Renaud Jacquemart, Ph.D., November 2025
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing – BioPharm International, Eric Langer, December 2025.
Survey: SUS Insufficient For 40% Of Biopharma – BioPharm International, Katrina Cordovado, December 2025.21 New Downstream Technologies Being Considered To Fix Capacity Problems – BioProcess Online, BioPlan Staff, January 2024.
Continuous Manufacturing: Many Want It, But Here’s Why Few Have It – BioProcess Online, Ioanna Deni, February 2024.
Report: Single-use Bioreactor Uptake Plateaued, Other SUT On The Rise – BioProcess Online, Ioanna Deni, August 2024.
Wish SUS Cost Less? Survey Says Your Peers Do, Too – BioProcess Online, Ioanna Deni, September 2024.
Embracing single-use innovations in a post-COVID era – Pharma Manufacturing, Ioanna Deni, September 2024.
Post-COVID Trends in Biopharma Contract Manufacturing – Contract Pharma, Ioanna Deni, September 2024.
Top 50 Biopharma Products Drive Growth in Contract Manufacturing – Contract Pharma, Dr. Smita Khanna, October 2024.
Survey Says Downstream Biomanufacturing Bottleneck Is Over – BioProcess Online, Ioanna Deni, October 2024.
The Waiting Game: A Bottom Is Imminent For Bioprocessing In China With A Return To Growth Two Years Away – CPhI Online Trends, Vicky Q. Xia, October 2024.
Great Majority of Biomanufacturers to Outsource More Production Over the Next Five Years – CPhI Online Trends, Ioanna Deni, October 2024.
Biopharmaceutical Manufacturing Growth – Pharmaceutical Technology, Shriya Bhatkhande, February 2023.
Single-Use Bioprocessing Technologies Enabling More Rapid Vaccines Production – American Pharmaceutical Review, Shriya Bhatkhande, April 2023.
Demand Surges for Cell and Gene Therapy Contract Manufacturing – Contract Pharma, Arvind S. Deol and Eric S. Langer, May 2023.
Post-COVID Supply-Chain Challenges Are Easing, Part 1: New Competition Is Changing Industry’s Buying Behavior – BioProcess International, Eric Langer and Bob Brooks, BioPhorum, June 2023.
Post-COVID Supply-Chain Challenges Are Easing, Part 2: Impact of Increased Vendor Competition on Pricing – BioProcess International, Eric Langer and Bob Brooks, BioPhorum, August 2023.
Staffing Shortages: Major Hurdle for Bioprocess Contract Manufacturing Services in 2023 – BioPharm International, Shriya Bhatkhande, August 2023.
Survey Results Show What Could Finally Make Sustainability Stick – BioProcess Online, Doug Nissinoff, September 2023.
CPHI report: China develops own biologics niche; no longer low-cost manufacturer – Bioprocess International, Vicky Xia, September 2023.
Symbiotic Success: How CDMOs Shaped a Decade of Biomanufacturing – Contract Pharma, Doug Nissinoff, October 2023.
Here’s Why Outsourcing To CDMOs Doubled In 13 Years – BioProcess Online, Erica Friedman, October 2023.
Modular And Single-use Tech Driving The Future Of Biomanufacturing – BioProcess Online, Erica Friedman, November 2023.
Top 50 Biopharma Products Drive Growth in Contract Manufacturing – Contract Pharma, Arvind S. Deol and Dr. Smita Khanna, November 2023.
Top Biomanufacturing Trends for 2022 – DCAT, Joel Ranck, January 2022
2021’s Bioprocessing Year In Review & 7 Key Takeaways – DCAT, Dr. Smita Khanna, January 2022
The Single-use Bioprocessing Bottleneck & Looking Ahead – BioProcess Online, Dr. Paul Spencer, April 2022
Biopharma In China: The Emerging Global Force Of Domestic Suppliers – BioProcess Online, Vicky Xia and Leo Yang, May 2022
Contract Manufacturing During COVID: Biologics revenue increases 29%, but will this growth be sustainable? – Contract Pharma, Eric Langer, May 2022
2022 Outsourcing Trends In Biopharmaceutical Manufacturing – BioProcess Online, Dr. Smita Khanna, June 2022
Bioprocessing Sees Continued Improvements In Batch Failure Reductions In 2022 – BioProcess Online, Joel Ranck, July 2022
BioPlan report: Buoyant bioprocess space will continue to shine post-COVID – BioProcess International, Dan Stanton, October 2022
Cell and Gene Therapy Contract Manufacturers Are Critical to Industry Success – Contract Pharma, Joel Ranck, September 2022
Will China become an innovation hub? CPHI Annual Report 2022 highlights four key trends in China’s emerging innovative biopharma industry – Pharmaceutical Manufacturing, Vicky Xia, October 2022The Biopharmaceutical Industry and Bioprocessing: What to Expect in 2021 – DCAT, Ronald A. Rader and Eric S. Langer, January 2021
Top Trends in Biomanufacturing 2020 – BioProcess International, Ronald Rader, February 2021
Economics of Perfusion Culture Media and Upstream Processing – American Pharmaceutical Review, Ronald Rader, Eric Langer, February, 2021
Worldwide Biopharmaceutical CMO Capacity Analysis – BioProcess International, Ronald Rader and Eric Langer, February 2021
The “New Normal”: Changing Perceptions on Bioprocess Intensification and Continuous Bioprocessing – BioProcess Online, Ronald A. Rader, March 2021.
Supply Chain Challenges Creating Hurdles to COVID-19 Vaccine Production [PDF] – BioPharm International, Jonathan S. Dakin, April 2021
Cell & Gene Therapy Bioprocessing: Demand For Better Process Control, Expertise & CMOs – BioProcess Online, Ronald Rader and Eric Langer, May 2021
Trends Affecting Biopharmaceutical Manufacturing – BioPharm International, David Lin, September 2021
Biopharma outsourcing goes international – Pharma Manufacturing, David Lin, October 2021
COVID-19 Spurs Growth Of China’s Domestic Bioprocessing Suppliers – BioProcess Online, Vicky Xia and Leo Yang, October 20212019 FDA Biopharmaceutical Approvals WP (published Jan 2020), Ronald Rader
Biosimilar Pipeline Experiencing 12% Annual Growth: A Progress Update – BioProcess Online, Ronald Rader, March 2020
Covid 19: Impact on Bioprocessing and Outsourcing – Contract Pharma, Ronald Rader and Eric Langer, May 2020
Biomanufacturing: Demand for Continuous Bioprocessing Increasing – Pharmaceutical Technology/BioPharm International, Eric Langer, June 2020
Cell And Gene Therapy Bioprocessing: Hiring And Capacity Crunch On The Horizon – BioProcess Online, Eric Langer June 2020
Culture Media Market Growth Drives Demand For New & Better Technologies – BioProcess Online, Kamna Jhamb, Ph.D., July 2020
COVID-19’s Impact On Bioprocessing: Insights From Industry Leaders – BioProcess Online, Ronald A. Rader, Eric S. Langer, and Kamna Jhamb, Ph.D, August 2020
Finding a Committed Bioprocess Supply Distributor in China: Managing Distributors in a Rapidly Growing Market – Genetic Engineering News, Vicky Xia and Leo Yang, September 2020
Samsung’s Drugmaking Future Includes a $2 Billion ‘Super Plant’ Bigger Than the Louvre – Wall Street Journal, Featuring quote from Eric S. Langer, Sept 2020
Cellular and Gene Therapies Face a Manufacturing Capacity Crunch – Pharmaceutical Technology/BioPharm International, Ronald Rader, September 2020
CONTINUOUS BIOPROCESSING: WHEN WILL WE SEE COMMERCIAL SCALE OPERATIONS? – Teknoscienze and ChemOutsourcing, Ronald Rader, October 2020
Biopharma trends accelerate: The pandemic has amplified the industry’s hiring problems and growth – Pharmaceutical Manfacturing, Ronald Rader, October 2020
Accelerating Trends in Bioprocessing COVID-19 Crisis Intensifies Need for Collaborative Solutions – American Pharmaceutical Review, Ronald A. Rader, Eric S. Langer, and Kamna Jhamb, Ph.D, October 2020
Biologics Manufacturing In China: Competition Heats Up Among CMOs & Their Clients – BioProcess Online, Vicky Xia and Leo Yang, October 2020
Global trends and growth opportunities in the biopharmaceutical product development and manufacturing – CPhI, Eric Langer, October 2020
Growth of Domestic Mab Pipeline, Regulatory Reform and New Investment is changing the landscape of Biologics CDMOs in China – CPhI, Vicky Xia and Leo Yang, October 2020
Cell and Gene Therapies: Challenges in Scale-up to Commercial Manufacturing – Results Healthcare, Ronald Rader, December 2020
Bioprocessing Year In Review: 11 Key Trends Accelerated By COVID-19 – BioProcess Online, Ronald Rader and Eric Langer, December 2020
Biomanufacturing Capacity and Supplies: COVID’s Impact – DCAT, Ronald Rader and Eric Langer, December 2020The Outlook for CMO Outsourcing in 2019 – BioPharm International, Jan 2019, Ronald Rader and E. Langer
Worldwide Biopharmaceutical CMO Capacity Analysis – Feb 2019, BioProcess International, Ronald Rader and E. Langer
Part 2 – Can China Become a Top Destination for Biologics Manufacturing? – Market Research Blog, Feb 18, 2019, Eric Langer
China Can Be Ignored No Longer: Long-Term Biopharmaceutical Opportunities Based on Near-Term Demonstrated Growth – BioProcess International, March 2019, Vicky (Qing) Xia and E. Langer
Biosimilars Set to Further Expand the Biopharmaceutical Market – American Pharmaceutical Review, March 2019, Ronald Rader and E. Langer
CMOs Leading the Way on Single-Use Systems Adoption – Pharmaceutical Technology, March 2019, Ilene Roizman and E. Langer
Biosimilars Pipeline Shows Remarkable, Sustained Growth – BioProcess Online, March 2019, Ronald Rader
Disposables/Single-Use Roundtable – American Pharmaceutical Review, March 2019, Eric Langer
Bioprocessing Facilities and FDA Inspection Problems – BioPharm International/Pharmaceutical Technology, May 2019, Ronald A. Rader
China Looks Inward and Outward: Investments in US and EU Biopharmaceutical Companies Are on the Rise – BioProcess International, May 2019, Vicky Xia and Eric S. Langer
Trends In Single-Use System Adoption In The Biopharma Industry – BioProcess Online, June 2019, Ilene Roizman
Good Manufacturing Practice in China: Equipment Strategy and Quality Management to Compete with the West – BioProcess International, June 2019, Vicky Xia
Outsourcing in China: How far can it go? – Contract Pharma, July 2019, Vicky Xia
Asia Bioprocessing Capacity Trends: Overall Growth, But Cell Therapy Shortages Loom – BioProcess Online, August 2019, Vicky Xia
Trends To Watch In China’s Biopharma Industry – BioProcess Online, October 2019, Vicky Xia
China’s single-use craze – Pharma Manufacturing, October 2019, Vicky Xia
Trends in Biopharma Contract Manufacturing in China and India – CPhI, November 2019, Vicky Qing Xia & Ronald A. Rader
Biopharma Over 20 Years – Contract Pharma, K. John Morrow, Jr. and E. Langer, November 2019
The next decade of cleanrooms – Pharmaceutical Manufacturing, Ronald A. Rader, December 2019
Biopharma Year in Review – Looking Ahead to 2020 – Pharmaceutical Online/BioProcess Online, December 2019, K. John Morrow Jr. and E. LangerBiosimilars on Cusp of Far-Reaching Impact; BioCompare; January 2018, Ronald A. Rader
Current Challenges in Bioprocesses Development; Pharmaceutical Technology; March 2018, Ronald A. Rader
CMOs & Biosimilars Mfg. in the U.S.; Contract Pharma; April 2018, Eric S. Langer and Ronald A. Rader
Contract Biomanufacturing in China: Creating a New Segment; Contract Pharma; April 2018, Vicky Xia and Leo Yang.
eBook: The Commercial Expression Systems Market — What Has Changed in the Past Decade; BioProcess International; May 2018, R. Rader
Demand for Capacity Drives China’s Biomanufacturing Expansion; BioProcess International; June 2018, Vicky Qing Xia and Leo Cai Yang
Fifteen Years of Progress: Biopharmaceutical Industry Survey Results; BioPharm International; July 2018, R. Rader
Biopharmaceutical Manufacturing is Shifting to Single-Use Systems. Are the Dinosaurs, the Large Stainless Steel Facilities, Becoming Extinct?;American Pharmaceutical Review; October 2018, E. Langer.
Top 12 Biopharma Manufacturing Trends; Genetic Engineering News; October 2018, E. Langer.
Improving Training in Biopharmaceutical Manufacturing; BioProcess Online; October 2018, I. Roizman and E. Langer.
7 Reasons There Was Never Going To Be A Bioprocessing Capacity Crunch; Outsourced Pharma; October 2018, Louis Garguilo (interview with R. Rader and E. Langer).
eBook: Biopharma Manufacturing Markets: Biomanufacturing contract services and supplies markets continues to expand; Contract Pharma; November 2018, R. Rader and E. Langer.
Staffing shortage leaving blockbuster biologics undeveloped, says expert; BioProcess International; November 2018, Dan Stanton (interview with E. Langer).
eBook: Single-Use Bioprocessing Equipment Trends and Adoption by CMOs; Pharmaceutical Technology; November 2018, R. Rader and E. Langer.
Part 1 – China Biopharmaceutical Growth Exceeding Western Projections – Market Research Blog, Nov 28, 2018, Eric Langer
Top Trends In The Biopharmaceutical Industry And Bioprocessing For 2019; BioProcess Online; December 2018, R. Rader and E. Langer.Overcoming The Manufacturing Hurdles Of Cell & Gene Therapy; BioProcess Online; February 2017, R. Rader
Modular Bioprocess Facilities Expanding Capacity in China; Genetic Engineering News; March 2017, V. Xia
CMOs Hiring Constraints: Cell Therapy Manufacturing Expecting Future Challenges; Contract Pharma; March 2017, E. Langer
Biosimilar Markets and Regulation: Which Countries Are Going All In?; BioProcess International; April 2017; R Rader
Staffing for China’s Rapidly Growing Biomanufacturing Industry; Pharmaceutical Technology; April 2017, V. Xia
CMOs & Biosimilars Mfg. in the U.S.; Contract Pharma; April 2017, E. Langer and R. Rader
Trends in Bioprocess Automation: Quality Control and Process Analytical Technology in High Demand; BioProcessing Journal; Spring 2017, K. Estes and E. Langer
Driving Bioprocessing Efficiency; Pharmaceutical Manufacturing; May 2017, K. Estes and E. Langer
China Biopharma: Is a Wave of GMP Exports in Our Future?; PharmaFocus Asia; May 2017, V. Xia, L. Yang, E. Langer
Update on Continuous Bioprocessing: From the Industry’s Perception to Reality; Pharmaceutical Technology; June 2017, K. Estes and E. Langer
Chinese And Indian GMP Biologics Exports: Surveying The Current Landscape; BioProcess Online; June 2017, V. Xia, L. Yang, E. Langer
Trends in New Technologies & Budgets; Contract Pharma; June 2017, E. Langer
Trends in Biopharma Contract Manufacturing in China and India; Pharmaceutical Outsourcing; June 2017, V. Xia and R. Rader
2 part series – Chinese & Indian Expectations For GMP Biologics Exports — A Comparative Assessment; BioProcess Online; July 2017, V. Xia, L. Yang, E. Langer
Current Trends in Analytical Testing; Contract Pharma; May 2017, E. Langer
Biosimilars Paving The Way For Cost-Effective Bioprocessing; BioProcess Online; August 2017, R. Rader and E. Langer
Outsourcing Trends in Biopharmaceutical Manufacturing; Pharmaceutical Outsourcing; September 2017, E. Langer
Trends and Growth in Single-Use System (SUS) Adoption; American Pharmaceutical Review; October 2017, E. Langer
Downstream Gears Up; Pharmaceutical Manufacturing; November 2017, E. Langer
Cell and Gene Therapies: Industry Faces Potential Capacity Shortages; Genetic Engineering News; November 2017, Ronald Rader
Alternatives to Protein A: Who’s Investigating?; Genetic Engineering News; February 2016, E. Langer
New Technologies for Fill-Finish; CMOs Are Well Positioned as Early Adopters; Genetic Engineering News; February 2016, E. Langer
Taking Stock of Biopharma’s Outsourcing Markets; Contract Pharma; February 2016, E. Langer
CMOs Step Up in Areas Where BioPharma is Short-Staffed; Pharmaceutical Outsourcing; March 2016, E. Langer
What’s Holding Back Single-Use Adoption?; Pharmaceutical Processing; March 2016, E. Langer
4 Key Trends In Biopharmaceutical Manufacturing In 2016; BioProcess Online; April 2016, E. Langer
Future Manufacturing Strategies for Biosimilars; BioProcess International; May 2016, R. Rader and E. Langer
Outsourcing of Biomanufacturing in 2016; Pharmaceutical Technology; May 2016, E. Langer
Biosimilars Segment—A Fast-Moving Blur; Genetic Engineering News; June 2016, E. Langer
Biomanufacturing Outsourcing Budgets Grow, Slowly; Pharmaceutical Technology; June 2016, E. Langer
Microbial Platforms Set for Rapid Growth; Genetic Engineering News; July 2016, E. Langer
Contract Manufacturing Budget Trends: Study shows where the money is, and isn’t, flowing; Contract Pharma; July 2016, E. Langer
Biosimilars Pipeline Analysis: Many Products, More Competition Coming; BioProcess Online; July 2016, R. Rader
CMOs and Innovation; Pharmaceutical Outsourcing; August 2016, E. Langer
Hiring Difficulties Compound Downstream Processing Woes; Genetic Engineering News; September 2016, E. Langer
Economics of In-House Buffer Preparation: Evaluating the cost effectiveness of keeping basic ops in-house; Contract Pharma; September 2016, E. Langer
Biopharmaceutical Manufacturing Globalization Continues; Pharmaceutical Outsourcing; September 2016, E. Langer
Average Batch Failure Rate Worsens; Genetic Engineering News; October 2016, E. Langer
Fill/Finish Outsourcing: This key bioprocessing segment is expecting continued growth; Pharmaceutical Technology; October 2016, E. Langer
Continuous Bioprocessing Overtakes Single-Use On List Of Top Technology Trends; BioProcess Online; October 2016, E. Langer
Year-End Trends in Biopharma Contract Manufacturing; Contract Pharma; November 2016, E. Langer
Manufacturing Costs Will Be Critical to Biosimilars’ Success; Pharmaceutical Manufacturing; November 2016, R. Rader
Biopharmaceutical Manufacturing Growing Rapidly in China; Genetic Engineering News; December 2016, E. Langer
Biosimilars Supporting Contract Manufacturers’ Growth: Biosimilars may be the key to CMO growth; Pharmaceutical Technology; December 2016, E. Langer
2017 Biopharmaceutical Trends — Opportunities For The New Year; BioProcess Online; December 2016, E. LangerFill/Finish Capacity Use for Biologics; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; January 2015, E. Langer
Biosimilars Impacting CMO Capacity; Pharmaceutical Outsourcing; February 2015; E. Langer
7 Top Trends in Biomanufacturing Outsourcing; Contract Pharma; January 2015; E. Langer and J.C. Lupis
CMO’s Plan for Capacity Expansions; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; March 2015, E. Langer
30 Years of Upstream Productivity Improvements; BioProcess International; February 2015; R. Rader and E. Langer
A Fully Disposable Bioprocessing Facility: Is it on the horizon?; Pharma IQ; February 2015; E. Langer
Outsourcing Budgets Continue to Shine: Preliminary study data indicates continued spending on outsourcing; Contract Pharma; April 2015, E. Langer
Biomanufacturing Outsourcing Globalization Continues; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; May 2015; E. Langer
Leachables And Extractables In Single-Use: Trends and Expectations Over Plastics Innovation; BioProcess Online, LSL; March 2015; E. Langer
Biosimilars Improving Efficiency, Cost for All Biologics; Contract Pharma; April 2015, E. Langer
BioPharma Industry Seeks Downstream Processing Advances; Pharmaceutical Processing; June 2015; E. Langer
Another In-House Operation Gets Outsourced; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; June 2015; E. Langer
Key Trends Shaping Fill/Finish Operations From Single-Use Adoption to CMO Acquisitions— Trends to Watch for This Year; American Pharmaceutical Review/Pharmaceutical Outsourcing; May 2015; E. Langer
Critical Trends Driving BioManufacturing Production Strategies; Pharmaceutical Manufacturing; June 2015; E. Langer
CMOs Demanding Easier-to-Integrate Single-use Devices; Contract Pharma; May 2015; E. Langer and J.C. Lupis
Single-Use Standardization: Is It Holding Back The Biopharma Industry?; BioProcess Online, LSL; June 2015; E. Langer
Hiring in Biopharma: Rapid Industry Growth is Creating Bottlenecks; Pharmaceutical Processing; July 2015; E. Langer
Getting to Yes; Contract Pharma; July 2015; E. Langer
New Technologies for Downstream Efficiencies; Pharmaceutical Manufacturing; June 2015; E. Langer
Outsourcing Becoming More Cost Competitive; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; August 2015; E. Langer
Is Biopharma Ready to Say Goodbye to Batches?; Medicine Maker; August 2015; E. Langer
CMOs Concerned With Cost of Single-Use Equipment; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; September 2015; E. Langer
CMOs Are Willing to Pay for More Innovation; Contract Pharma; September 2015; E. Langer
Bio Pharma Manufacturing’s Top 15 Trends for 2015; Pharmaceutical Manufacturing; August 2015; E. Langer and J.C. Lupis
Globalization Hits Biopharma Contract Manufacturing; Contract Pharma; October 2015; E. Langer
Advances in Bioprocessing: Single-Use and Stainless Steel Technologies; BioProcessing International; December 2015; E. Langer
Biopharmaceutical Manufacturing: Historical and Future Trends in Titers, Yields, and Efficiency in Commercial-Scale Bioprocessing; BioProcessing Journal; Winter 2015; R. Rader and E. Langer
Are CMOs Really Going to See a Capacity Pinch?; Genetic Engineering News; November 2015; E. Langer
2015 in Review: 6 Key Trends Affecting CMOs; Contract Pharma; November 2015; E. Langer
Continuous Bioprocessing in Operation; Genetic Engineering News; December 2015; E. Langer
Cell Culture Media Process Optimization; Genetic Engineering News; December 2015, E. Langer
Regulatory Concerns For Facilities Of The Future: Does Flexibility Come With A Cost?; BioProcess Online, LSL; December 2015; E. LangerYear in Review: Key Outsourcing Trends to Watch This Year; Pharmaceutical Outsourcing, January 2014; E. Langer
Novel Expression Systems Opening CMO Opportunities; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, January 2014; E. Langer
Who’s Improving Bioprocessing In 2014; Life Science Leader, January 2014; E. Langer
Continuous Bioprocessing and Perfusion: Wider Adoption Coming as Bioprocessing Matures; BioProcessing Journal, Spring 2014; E. Langer
Outsourcing trends in Biopharmaceutical Manufacturing; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, February 2014; E. Langer
Single Use Technologies in Biopharmaceutical Manufacturing: A 10-year Review of Trends and the Future; Engineering in Life Sciences, May 2014; E. Langer
Too Much CMO Capacity? Biomanufacturers plan their 2018 capacity expansions; Contract Pharma, March 2014; E. Langer
Best Practices in Biomanufacturing Supplier Relations: Reducing Raw Materials Risks; Life Science Leader; February 2014; E. Langer
Bioprocess Advances Drive Vaccine Manufacturing in Developing Countries; BioProcess International, February 2014; E. Langer and R. Rader
Innovation Is This Year’s Magic Wand; Genetic Engineering News, March 2014; E. Langer
Powders and Bulk Liquids; Bioprocess International, March 2014; E. Langer and R. Rader
Innovation in Pre-packed Disposable Chromatography Columns; BioPharm International Supplement, March 2014; E. Langer
Manufacturers Open Their Wallets for Outsourcing: Accessing Technical Expertise and Cutting Costs; BioProcess International, April 2014; E. Langer
Biopharma Quality Management Best Practices: An Approach to Quality Initiatives; Life Science Leader, April 2014; E. Langer
Outsourcing No Longer Just for Cost-Cutting; Pharmaceutical Technology, May 2014; E. Langer
CMOs Most Critical to Success Factors; Pharmaceutical Processing, April 2014; E. Langer
Bioprocessors Demanding Single-Use Sensors Best Practices; Life Science Leader, May 2014; E. Langer
Bioprocessing Trends to Expect in 2014; Genetic Engineering News, June 2014; E. Langer
Bio/Pharma Industry Improves Downstream Operations Best Practices: Membrane Technology Options; Life Science Leader, July 2014; E. Langer
BioPharma Unhappy With Suppliers’ Progress on Single-Use Hookups; BioProcess International, September 2014; E. Langer
Biopharm Executives Point to Better CMO Performance; Contract Pharma, October 2014; E. Langer
Outsourcing Grows in Europe; Pharmaceutical Technology Europe, August 2014; E. Langer
Outsourcing Media and Buffer Prep; Contract Pharma, September 2014; E. Langer
Targeting Different Offshore Destinations; Pharmaceutical Technology, September 2014; E. Langer
Outsourcing Economic Models Are Changing; Life Science Leader, September 2014; E. Langer
Moving Beyond the Batch: Best Practices, Opportunities and Challenges in Continuous Bioprocessing; Life Science Leader, October 2014; E. Langer
Bioprocessing Challenges of Antibody-Drug Conjugates; BioProcess International, October 2014; R. Rader
Budgets Increase to Support Single-Use Bioprocessing; BioPharm International, November 2014; E. Langer
Single-use Disposables are Future Proofing Biopharmaceutical Manufacturing; PharmaIQ, October 2014; E. Langer
The Biosimilars Opportunity: 4-years of Waiting; Life Science Leader, October 2014; E. Langer
Risks and Rewards in the U.S. BioSimilars Pipeline; Pharmaceutical Manufacturing, October 2014; E. Langer
The US Biosimilars Future Is Hard to Predict: Global Health Policy, Innovation, Prices, and Profits Are All at Stake; BioProcess International, December 2014
Biomanufacturing Industry Not Providing Employees the Tools to Succeed; Life Science Leader, November 2014; E. Langer
Year in Review: Trends in Biopharma Manufacturing Outsourcing; Pharmaceutical Technology, December 2014; E. LangerCritical Innovation BioProcessing Trends For 2014; Life Science Leader, December 2013; E. Langer
Disposable Chromatography: Options Are Increasing Requirements for greater productivity and efficiency are moving interest toward disposable options; Genetic Engineering News, December 2013; E. Langer
Biopharmas Increasingly Satisfied With Vendors Of Single-Use Products; Life Science Leader, December 2013; E. Langer
Future proofing biopharmaceutical manufacturing: the industry seeks a leaner version of itself; Future Science, December 2013; E. Langer and R. Rader
CMOs Demanding More Innovations; Contract Pharma, November 2013
Innovation In Stainless-Steel Bioprocessing; Life Science Leader, October 2013; E. Langer and R. Rader
Seeking Innovation to Solve Persistent Problems; Pharmaceutical Manufacturing, November 2013; E. Langer
Bio-CMO Capacity Constraints; Contract Pharma, September 2013; E. Langer
Industry Adoption of Membrane Adsorbers; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, October 2013; E. Langer
Client Relationships: How CMOs Can Avoid The Pitfalls; Life Science Leader, October 2013; E. Langer
Innovation In Alternative Chromatography; Life Science Leader, October 2013; E. Langer
PAT Adoption Hurdles Remain; Pharmaceutical Manufacturing, October 2013; E. Langer
Making the Best of a Bad CMO-Client Relationship; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, September 2013; E. Langer
Innovation In Expression Systems Yields Increase Productivity; BioProcess Online, August 2013; E. Langer
Bioprocessing Advances in Vaccine Manufacture; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, September 2013; E. Langer and R. Rader
What Happened to Outsourcing in Asia?; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, August 2013; E. Langer
Innovation In Disposable Connectors; Life Science Leader, July 2013; E. Langer
Demand For Innovation In High-Value Bioprocessing; Life Science Leader, June 2013; E. Langer
Disposable Applications Penetrate Biomanufacturing Market; Pharmaceutical Manufacturing, June 2013; E. Langer
Keeping New Technologies Coming; BioProcess International, June 2013; E. Langer
Outsourcing’s Modest Role as a Cost-Containment Strategy; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, May 2013; E. Langer
CMOs Leading The Way In Biopharma Innovation – No Herd Mentality; Life Science Leader, May 2013; E. Langer
Outsourcing of Fill-Finish Operations Continues; Pharmaceutical Processing, April 2013; E. Langer
Global Changes in Biomanufacturing; A retrospective analysis of CMO Trends; Contract Pharma, April 2013, E. Langer
Single-use Bioprocessing Sensor Innovation Is In Need; Life Science Leader, April 2013; E. Langer
Vendors Ignore Calls For Innovation In Assays; Life Science Leader, April 2013; E. Langer
Biopharma Continues Globalization Efforts; Global Corporate Xpansion, April 2013; E. Langer
Focus on Efficiency: Single-use, analytical methods and downstream processing at the forefront.; Pharmaceutical Manufacturing, March 2013; E. Langer
Outsourcing of Non-traditional Protein Expression Systems Increases; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, April 2013; E. Langer
The Big Squeeze; European Biopharmaceutical Review, Spring 2013; E. Langer
Fill-Finish Innovation: Showing Sparks of Life; Contract Pharma, March 2013; E. Langer and R. Rader
Innovation In Assays And Analytical Methods Urgently Needed; Life Science Leader, February 2013; E. Langer
Biopharmas Increasingly Satisfied With Vendors Of Single-Use Products; Pharmaceutical Online, February 2013; E. Langer
The Future of BioPharma; BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, February 2013; E. Langer
Offshoring Biomanufacturing; Pharmaceutical Technology, February 2013; E. Langer
Breaking the Biotech Bottleneck: Downstream capacity still lags behind upstream, but shortages are now “acute” rather than “chronic; Pharmaceutical Manufacturing, January 2013; E. Langer
Sponsors Look to Asia for Potential Contract Partners; BioProcessing International, January 2013; E. Langer
Biopharma Outsourcing Leveling Out; Pharmaceutical Online, August 2012, Eric Langer
Gauging Biopharm Outsourcing; Pharmaceutical Technology August 2012, Eric Langer
CMOs and Biodevelopers Taking Different Approaches to DSP Problems: CMOs Get Serious About New Technologies; E. Langer, Pharmaceutical Outsourcing, July 2012
Top 50 (or so) Biopharma Products: Ranking the top 57 biopharma products by 2011 revenues – Contract Pharma, Ronald Rader, July 2012
BioPharma Industry Gives the Nod to Single-Use Bioreactors; E. Langer, Genetic Engineering News, July 2012
Biomanufacturing Innovation; E. Langer, BioPharm International, July 2012
Biopharmas Increasingly Satisfied with Vendors of Single-Use Products; E. Langer, Life Science Leader, July 2012
Biomanufacturers Looking for Single-Use Innovations; E. Langer, Pharmaceutical Online, June 2012
Biomanufacturing Shows Signs of Maturity, PAT Adoption; E. Langer, June 2012
Biomanufacturing Innovation; E. Langer, Pharmaceutical Technology, June 2012
25 Years of Biopharma Industry Growth; E. Langer, BioPharm International, June 2012 Special Issue
Hiring In Biopharma — Where Are The Jobs Going Next?; E. Langer, Life Science Leader, May 2012
10 years of biomanufacturing: Industry maturity shown in the shifts toward process improvement; E. Langer, BioProcess International, May 2012
Single-Use Technologies Used Less for Downstream Purification Issues; E. Langer, Pharmaceutical Online, May 2012
Bio-Growth Slowing?; E. Langer, Contract Pharma, May 2012
Productivity Focus: CMOs Look to Get More From Their Employees; E. Langer, Genetic Engineering News, May 2012
BioManufacturers Increasing Budgets for New Technologies; Eric Langer, BIO, May 3, 2012
CMOs on the Hunt for Disposable Solutions; E. Langer, Pharmaceutical Processing, April 2012
BioPharma Industry Getting Comfortable with Complex Single Use Devices; E. Langer, Pharmaceutical Online, March 2012
Biopharma Vendor Satisfaction: Are Suppliers Doing What’s Best For The Industry?; E. Langer, Life Science Leader, March 2012
Industry Adopting More Complex Devices; E. Langer, Contract Pharma, March 2012
Pharmaceutical Outsourcing Trends: The Next Decade; E. Langer, BioPharm International, March 2012 Special Issue
Are Downstream Problems Finally Being Resolved?; E. Langer, BioProcess International, March 2012
Biosimilars and Biobetters; Eric Lanager, Pharmaceutical Processing, Feb 2012
Biomanufacturing Outlook; Eric Langer, Pharmaceutical Technology, Feb 2012
Biopharma Manufacturers Looking for Product Innovation; E. Langer, Life Science Leader, February 2012
Single Use Biomanufacturing Devices in High Demand; E. Langer, Pharmaceutical Online, February 2012
Upstream Single-Use Bioprocessing Systems; Ron Rader and Eric Langer, BioProcess International, February 2012
Biopharmaceutical Industry in 2012: Optimism on the Rise; E. Langer, Pharmaceutical Technology, February 2012
Biopharma Industry Enthusiastic About 2012; Eric Langer, BIO, January 12, 2012
Limited Analytical Technologies Are Inhibiting Industry Growth; E. Langer, October 2011
Top 1000 Global Biomanufacturing Facilities- Insights from real-time ranking of global biomanufacturing capabilities.; E. Langer, BioPharm International, August 2011
Can Outsourcing GMP Operations to China Really Work?; E. Langer, Life Science Leader, August 2011
Single Use Bioreactors Lead in New Use and Market Penetration; E. Langer, Pharma IQ, August 2011
Single Use Devices-Whats REALLY Holding Up Adoption?; E. Langer, Life Science Leader, July 2011
Positive Trends in Biomanufacturing Budgets: Biopharma and Vendor Budgets Are Up For the First Time in Three Years; E. Langer, BioProcessing Journal, July 2011
Hiring In Biopharma — Where Are The Jobs Going Next?; E. Langer, Life Science Leader, July 2011
Bio-Outsourcing On the Rise: Fewer companies go 100% in-house; E. Langer, Contract Pharma, June 2011
Will Perfusion Be the Next Revolution in Bioprocessing?; E. Langer, BioProcess International, June 2011
Offshoring Biomanufacturing: China rises to the top as a destination for international sourcing; E. Langer, BioProcess International, June 2011
Biomanufacturing Budget Bump-2011’s Spending Upswing; E. Langer, PharmaIQ, June 2011
Top 1000 Biomanufacturing Facilities: Knowing where key biomanufacturing facilities are located around the world is essential for decision-making.; E. Langer, BioPharm International, June 2011
Trends in Biopharmaceutical Industry: Budgets Returning…Investing In Innovation…Productivity & Cost Control; E. Langer, Pharmaceutical Manufacturing, June 2011
Biotech Budgets: Whose Departments Are Winning?; E. Langer, Life Science Leader, June 2011
Biopharma Wants Better Upstream Bioprocessing Technologies; E. Langer, Pharmaceutical Technology, May 2011
Downstream Process Bottlenecks: Industry Demanding Better Technologies; E. Langer, Genetic Engineering News, May 2011
Hiring Trends in Biopharma; E. Langer, Ashton Tweed, May 2011
Time to Build ‘Relationship’ into the Outsourcing Process; E. Langer (BioData Points), Life Science Leader, May 2011
Single Use Technologies Changing the Biomanufacturing Landscape; E. Langer, Life Science Leader, May 2011
Single Use Trends Boosting Adoption or Vendor Satisfaction; E. Langer, Pharmaceutical Manufacturing, May 2011
New Plant Expression Systems Drive Vaccine Innovation and Opportunity; E. Langer, BioProcess International, April 2011
Productivity Bottlenecks Drive the Demand for Innovation; E. Langer, BioProcess International, March 2011
Improved Downstream Technologies Are Needed to Boost Single-Use Adoption; E. Langer, BioProcess International, March 2011
Single-Use Products in BioManufacturing: Innovations Driving the Industry; E. Langer, BioProcess International, March 2011
Changes Underway for Biopharmaceutical Outsourcing More crucial biomanufacturing operations are expected to be outsourced
E Langer Presents 2011 Trends for Life Science Leader Journal; E. Langer, Life Science Leader Journal, January 2011
European Biomanufacturing Efficiency Outstripping US: Outlook for Capacity Utilisation Through 2015; E. Langer, European Biopharmaceutical Review, January 2011Biofuels: Road to Recovery; D. Mousdale, BioFuels International, December 2010
Outsourcing Winners in 2014: Post recession and beyond; E. Langer, Pharmaceutical Technology, Nov 2, 2010
Trends to Watch in the Biopharmaceutical Industry; E. Langer, Pharmaceutical Executive, Supplement for Nov. 2010
Regulatory Challenges Impede Adoption of new Downstream Technologies; E. Langer, BioPharm International, October 2010
Plant Expression Systems Growing Rapidly, Vaccines Manufacturers Leading the Way; E. Langer, Genetic Engineering News, October 15, 2010
Downstream Disposables: The Missing Link in the Disposables Chain: Acceptance in has been slow.; E. Langer, BioPharm International, August 1, 2010
Project Managers Wanted: Relationship management is a limiting factor to growth in biomanufacturing outsourcing; E. Langer, Pharmaceutical Technology, Aug 2, 2010
Perfusion Bioreactors Are Making a Comeback, But Industry Misperceptions Persist; E. Langer, BioProcessing Journal, Summer 2010
Managing the Client-Contractor Relationship Increased bio/pharmaceutical outsourcing demands new management skills; E. Langer, Chimica Oggi / CHEMISTRY TODAY – vol 28 n 4 – July/August 2010
Bio/pharma outsourcing: Strategic initiative, or just passing off low-end jobs; E. Langer, Chemical Week; July 2010
Will Protein A Be the Long-Term Solution for Your Purification Needs? Cost-effective purification technologies.; E. Langer, BioPharm International, June 2010
As Biopharma Matures: Working Harder, Getting Leaner; E. Langer, Pharmaceutical Manufacturing, April 28, 2010
Biopharma Outsourcing Trends: Client-contractor relationships grow more complex; E. Langer, Contract Pharma, April 2010
Waste Not, Want Not: Restructuring in the biopharmaceutical industry is renewing a focus on resource optimization; E. Langer, Pharmaceutical Technology, April 2, 2010
Downstream Processing: Promising Technologies are on the Horizon; Beyond traditional chromatography; E. Langer, BioPharm International, March 2010
Contract Manufacturing Bucks Economic Downturn: Practitioners Cite Depth of Experience and Formation of a More Mature and Stable Business Model; E. Langer, Genetic Engineering News, February 2010
Single-Use Technology in Biopharmaceutical Manufacture, part 1; Brian Lee, Eric Langer, Ran Zheng, Wylie, Book Chapter, February 2010
On the Horizon: New Expression Systems to Become Common Industry Platforms; E. Langer, Biopharm International (June 2009)
Trends in Single-use Bioproduction; E. Langer, BioProcess International (April 2009)
Expanding Expression: Beyond CHO, E coli and Yeast; E. Langer, EBR-European Biopharmaceutical Review (April 2009)
Biopharmaceutical Products in US and European Markets, 5th Edition; Ron Rader, BioPlan Associates, Inc, July 2006
Capacity Bottleneck Squeezed by Downstream Processes; E Langer, J Ranck, BioProcess International, March 2006
The ROI Case: Economic Justification for Disposables in Biopharmaceutical Manufacturing; Eric S. Langer, J. Ranck, BioProcess International, October 2005
Biopharmaceutical Manufacturing: No single approach will resolve cost issues.; Genetic Engineering News, November 15, 2004
Big Shifts in Outsourcing of Biopharmaceutical Manufacturing—Half of Manufacturers to Outsource production by 2008; Genetic Engineering News, January 15, 2004
Gene Therapy–Dreams of Vectors in a Bottle; Genetic Engineering News, vol 17, no. 3, (February 1, 1997) pp. 8, 34
Pivotal Trial of Artificial Skin Advances Tissue Engineering Industry; Genetic Engineering News, volume 16, no. 2, (January 15, 1996) pp. 25
NIH Scientists Develop a Range of New Technologies for Tech Transfer; Genetic Engineering News, volume 14, no. 20, (May 15, 1992) pp. 7, 25
White Papers
The following aggregated White Papers are available by e-mail.
September BioPhorum COVID White Paper Sept 2022 [PDF]
Trends in Single-Use Bioprocessing 2D Bags Analysis March 2015 [PDF]
Novel Benchtop-Scale Single-Use Bioreactor: Attributes Assessment June 2014 [PDF]
Life Sciences Training and Education
Commercializing Life Sciences
E-mail BioPlan Associates to request purchase information
Training Needs in Biopharmaceutical Manufacturing
E-mail BioPlan Associates to request purchase information
Value of ROI in Life Sciences Marketing
E-mail BioPlan Associates to request purchase information
Newsletters
We offer the following free Newsletters for our subscribers.
BioFacilities News – Free, quarterly newsletter tracking news/trends in the biologics industry. 100s of sources filtered by our analysts’ 20+ years experience. Click here to receive a copy.
For the full version of our BioFacilities Newsletter, click here for more information about becoming a subscriber to our Top1000 Bio Database. Yearly subscriptions include the full quarterly newsletter.
BioChina News – Free, quarterly newsletter tracking news/trends in the China biopharmaceutical /pharmaceutical industry. Click here to receive a copy.
Click here for more information about becoming a subscriber to our Top100 China Directory Database. Yearly subscriptions available.